<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25751421</article-id><article-id pub-id-type="pmc">4353714</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0119539</article-id><article-id pub-id-type="publisher-id">PONE-D-14-50052</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Integrin &#x003b1;3&#x003b2;1 Signaling through MEK/ERK Determines Alternative Polyadenylation of the MMP-9 mRNA Transcript in Immortalized Mouse Keratinocytes</article-title><alt-title alt-title-type="running-head">Integrin &#x003b1;3&#x003b2;1 Controls Alternative Polyadenylation</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Missan</surname><given-names>Dara S.</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Mitchell</surname><given-names>Kara</given-names></name><xref ref-type="author-notes" rid="currentaff001"><sup>&#x000a4;</sup></xref><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>Subbaram</surname><given-names>Sita</given-names></name><xref ref-type="aff" rid="aff001"/></contrib><contrib contrib-type="author"><name><surname>DiPersio</surname><given-names>C. Michael</given-names></name><xref rid="cor001" ref-type="corresp">*</xref><xref ref-type="aff" rid="aff001"/></contrib></contrib-group><aff id="aff001"><addr-line>Center for Cell Biology and Cancer Research, Albany Medical College, Albany, New York, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Languino</surname><given-names>Lucia R.</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Thomas Jefferson University, UNITED STATES</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: DSM KM CMD. Performed the experiments: DSM KM SS. Analyzed the data: DSM KM SS CMD. Contributed reagents/materials/analysis tools: CMD. Wrote the paper: DSM CMD.</p></fn><fn fn-type="current-aff" id="currentaff001"><label>&#x000a4;</label><p>Current address: NYS Department of Health, Wadsworth Center, Albany, New York, United States of America</p></fn><corresp id="cor001">* E-mail: <email>dipersm@mail.amc.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>9</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>10</volume><issue>3</issue><elocation-id>e0119539</elocation-id><history><date date-type="received"><day>6</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>13</day><month>1</month><year>2015</year></date></history><permissions><copyright-year>2015</copyright-year><copyright-holder>Missan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0119539.pdf"/><abstract><p>Integrin &#x003b1;3&#x003b2;1 is highly expressed in both normal and tumorigenic epidermal keratinocytes where it regulates genes that control cellular function and extracellular matrix remodeling during normal and pathological tissue remodeling processes, including wound healing and development of squamous cell carcinoma (SCC). Previous studies identified a role for &#x003b1;3&#x003b2;1 in immortalized and transformed keratinocytes in the regulation of genes that promote tumorigenesis, invasion, and pro-angiogenic crosstalk to endothelial cells. One such gene, matrix metalloproteinase-9 (MMP-9), is induced by &#x003b1;3&#x003b2;1 through a post-transcriptional mechanism of enhanced mRNA stability. In the current study, we sought to investigate the mechanism through which &#x003b1;3&#x003b2;1 controls MMP-9 mRNA stability. First, we utilized a luciferase reporter assay to show that AU-rich elements (AREs) residing within the 3&#x02019;-untranslated region (3&#x02019;-UTR) of the MMP-9 mRNA renders the transcript unstable in a manner that is independent of &#x003b1;3&#x003b2;1. Next, we cloned a truncated variant of the MMP-9 mRNA which is generated through usage of an alternative, upstream polyadenylation signal and lacks the 3&#x02019;-UTR region containing the destabilizing AREs. Using an RNase protection assay to distinguish &#x0201c;long&#x0201d; (full-length 3&#x02019;-UTR) and &#x0201c;short&#x0201d; (truncated 3&#x02019;-UTR) MMP-9 mRNA variants, we demonstrated that the shorter, more stable mRNA that lacks 3&#x02019;-UTR AREs was preferentially generated in &#x003b1;3&#x003b2;1-expressing keratinocytes compared with &#x003b1;3&#x003b2;1-deficient (i.e., &#x003b1;3-null) keratinocytes. Moreover, we determined that &#x003b1;3&#x003b2;1-dependent alternative polyadenylation was acquired by immortalized keratinocytes, as primary neonatal keratinocytes did not display &#x003b1;3&#x003b2;1-dependent differences in the long and short transcripts. Finally, pharmacological inhibition of the extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK) pathway in &#x003b1;3&#x003b2;1-expressing keratinocytes caused a shift towards long variant expression, while Raf-1-mediated activation of ERK in &#x003b1;3-null keratinocytes dramatically enhanced short variant expression, indicating a role for ERK/MAPK signaling in &#x003b1;3&#x003b2;1-mediated selection of the proximal polyadenylation site. These findings identify a novel mode of integrin &#x003b1;3&#x003b2;1-mediated gene regulation through alternative polyadenylation.</p></abstract><funding-group><funding-statement>This work was supported by National Institutes of Health grants to CMD from the National Cancer Institute (R01CA129637) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (R21AR056390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="7"/><table-count count="0"/><page-count count="19"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>The integrin &#x003b1;3&#x003b2;1 is expressed highly in epithelial cells, where it is the major receptor for laminin-332 and certain other laminin isoform present in basement membranes [<xref rid="pone.0119539.ref001" ref-type="bibr">1</xref>]. &#x003b1;3&#x003b2;1 functions to maintain integrity of the basement membrane during embryonic development of the epidermis, and mutations in the gene that encodes the &#x003b1;3 integrin subunit cause basement membrane rupture and epidermal blistering in both preclinical mouse models and human patients [<xref rid="pone.0119539.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pone.0119539.ref004" ref-type="bibr">4</xref>]. In addition, overexpression of &#x003b1;3&#x003b2;1 occurs in tumors of the epidermis, breast, and other tissues, where it has been linked to promoting tumor growth and progression through the regulation of cell growth, survival, invasion and metastasis, as reviewed elsewhere [<xref rid="pone.0119539.ref005" ref-type="bibr">5</xref>, <xref rid="pone.0119539.ref006" ref-type="bibr">6</xref>].</p><p>Some &#x003b1;3&#x003b2;1-mediated tumor cell functions may be due to its ability to induce the expression of matrix metalloproteinase-9 (MMP-9) [<xref rid="pone.0119539.ref007" ref-type="bibr">7</xref>&#x02013;<xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>]. Indeed, MMP-9 is an important regulator of tumor angiogenesis and invasion with a prominent role in the development of SCC and other carcinomas [<xref rid="pone.0119539.ref010" ref-type="bibr">10</xref>&#x02013;<xref rid="pone.0119539.ref012" ref-type="bibr">12</xref>]. Early studies identified mRNA stability as an important post-transcriptional mechanism of MMP-9 gene regulation in response to cytokines, growth factors, and other stimuli [<xref rid="pone.0119539.ref013" ref-type="bibr">13</xref>&#x02013;<xref rid="pone.0119539.ref015" ref-type="bibr">15</xref>], as well as to integrin &#x003b1;3&#x003b2;1 [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>]. Moreover, we previously demonstrated that epidermal keratinocytes acquire &#x003b1;3&#x003b2;1-dependent expression of MMP-9 during immortalization [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>]. However, the mechanism whereby &#x003b1;3&#x003b2;1 controls MMP-9 mRNA stability has not been determined.</p><p>Post-transcriptional control of mRNA stability is widely documented as an important gene regulatory mechanism in a variety of normal and pathological tissue remodeling processes, including cancer, as reviewed elsewhere [<xref rid="pone.0119539.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0119539.ref018" ref-type="bibr">18</xref>]. A significant mode of mRNA stability occurs through AU-rich elements (AREs) that reside in the 3&#x02019;-untranslated region (3&#x02019;-UTR) and control the rate of mRNA decay [<xref rid="pone.0119539.ref018" ref-type="bibr">18</xref>]. Class I AREs consist of an AUUUA/U pentamer which is often embedded in a uracil-rich region, and are usually present in multiple copies within the 3&#x02019;-UTR of mRNAs with short or variable half-lives. Generally speaking, ARE-containing mRNAs are labile unless stabilized in response to appropriate extracellular cues. Estimates of the number of human genes that contain AREs range from 5% to 11%, and the presence of AREs is conserved in &#x0003e;50% of mouse and human homologous genes [<xref rid="pone.0119539.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="pone.0119539.ref020" ref-type="bibr">20</xref>]. AREs regulate mRNA stability by binding to specific RNA-binding proteins (RBPs). As reviewed extensively elsewhere, examples include AUF-1, isoforms of which have been implicated in both mRNA stability and instability, and members of the ELAV family such as HuR, which normally act to stabilize mRNAs [<xref rid="pone.0119539.ref018" ref-type="bibr">18</xref>]. RBP function can be regulated in response to a variety of stimuli through signals mediated by stress-activated kinases and cell membrane receptors. ARE-mediated control of MMP-9 mRNA stability in response to signals from specific cytokines, nitric oxide, or integrins has been documented [<xref rid="pone.0119539.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0119539.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0119539.ref021" ref-type="bibr">21</xref>].</p><p>Alternative polyadenylation (APA) is a widely used mechanism of controlling mRNA stability through the generation of alternative mRNA transcripts with distinct 3&#x02019;-UTR sequences that vary in their ARE content (reviewed in [<xref rid="pone.0119539.ref022" ref-type="bibr">22</xref>]). For example, exclusion of AREs through APA can stabilize a mRNA transcript and lead to higher protein expression. Over half of mRNA-encoding genes in the human genome have multiple polyadenylation [poly(A)] sites, leading to the generation of mRNA variants within the coding regions or 3&#x02019;-UTR [<xref rid="pone.0119539.ref022" ref-type="bibr">22</xref>]. Importantly, APA as a means to generate truncated 3&#x02019;-UTRs that lack AREs has been linked to enhanced mRNA stability of pro-tumorigenic genes [<xref rid="pone.0119539.ref023" ref-type="bibr">23</xref>&#x02013;<xref rid="pone.0119539.ref025" ref-type="bibr">25</xref>]. While some integrins have also been linked to pro-tumorigenic gene expression [<xref rid="pone.0119539.ref026" ref-type="bibr">26</xref>], roles for integrins in controlling APA have not been explored previously.</p><p>In the current study, we sought to determine the mechanism through which the integrin &#x003b1;3&#x003b2;1 enhances MMP-9 mRNA stability in immortalized keratinocytes. Initial experiments using standard luciferase reporters for assessing ARE function revealed that the ARE-containing 3&#x02019;-UTR of MMP-9 confers reduced reporter gene expression whether or not &#x003b1;3&#x003b2;1 is present in the cells, which prompted us to explore whether this integrin instead controls APA that determines ARE content of the mRNA transcript. Indeed, the MMP-9 gene harbors a functional alternative poly(A) site in the 3&#x02019;-UTR that lies upstream of several AREs [<xref rid="pone.0119539.ref027" ref-type="bibr">27</xref>]. RNase protection assay (RPA) to detect the MMP-9 mRNA variant that is generated by usage of this proximal poly(A) site revealed that it is utilized significantly more in &#x003b1;3&#x003b2;1-expressing than in &#x003b1;3&#x003b2;1-deficient cells. Moreover, we showed that &#x003b1;3&#x003b2;1-dependent APA was acquired by immortalized keratinocytes, as this regulation was not detected in non-immortalized, primary keratinocytes. Finally, we provide evidence that &#x003b1;3&#x003b2;1-dependent APA of the MMP-9 mRNA occurs through a signaling pathway that involves extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinase (MAPK). Together, these data suggest a novel role for integrin &#x003b1;3&#x003b2;1 in immortalized keratinocytes in regulating APA, which in turn determines mRNA stability by controlling ARE content of the 3&#x02019;-UTR. To our knowledge, these data provide the first evidence that integrins can influence poly(A) site selection, representing a novel mode of integrin-mediated regulation of mRNA stability and gene expression.</p></sec><sec sec-type="materials|methods" id="sec002"><title>Materials and Methods</title><sec id="sec003"><title>Cell culture</title><p>The immortalized mouse keratinocyte (MK) cell lines, MK+/+ (MK-1.16) and MK&#x02212;/&#x02212; (MK-5.4.6), were derived from the epidermis of wild type or &#x003b1;3-null mice, respectively, as described previously [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>]. MK&#x02212;/&#x02212;: h&#x003b1;3 cells were generated from MK&#x02212;/&#x02212; cells stably transfected with human &#x003b1;3, as described [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>]. Epidermis-specific &#x003b1;3 knockout (&#x003b1;3eKO) mice are homozygous for a floxed &#x003b1;3 allele (&#x003b1;3<sup>flx/flx</sup>) and express Cre recombinase under control of the keratin-14 promoter (K14-Cre), as described [<xref rid="pone.0119539.ref028" ref-type="bibr">28</xref>]. Primary keratinocytes were isolated from &#x003b1;3eKO mice or control littermates lacking K14-Cre using established protocols [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>]. Culture conditions for primary keratinocytes and MK cell lines were as described in detail elsewhere [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>]. For some experiments, cells were treated for 24 hours with the MEK inhibitor, U0126 (10 &#x003bc;M), prior to analysis.</p></sec><sec id="sec004"><title>Transfection with luciferase reporter plasmids</title><p>CMV promoter/luciferase reporter plasmids, constructed in the pcDNA3 expression vector (Invitrogen), were generously provided by Dr. Joan Steitz (Yale University). In these plasmids, the 3&#x02019;-UTR of the firefly luciferase reporter gene was engineered to contain five repeated copies of either a consensus AU-rich ARE (ATTTA), or a control GC-rich sequence, as described [<xref rid="pone.0119539.ref029" ref-type="bibr">29</xref>]. MMP-9 promoter/luciferase reporter plasmids [pGL3-MMP-9(1.3kb)], constructed in the pGL3 Basic Luciferase Reporter Vector (Promega, Madison, WI), were generously provided by Dr. Wolfgang Eberhardt (Goethe-Universit&#x000e4;t Frankfurt am Main). These plasmids contained either the SV40 poly(A) signal (present in the pGL3 parent vector), or the ARE-containing 3&#x02019;-UTR from MMP-9 (lacking the proximal poly(A) site) inserted downstream of the firefly luciferase gene, as described [<xref rid="pone.0119539.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0119539.ref030" ref-type="bibr">30</xref>]. For transient transfections, MK cells were sub-cultured on laminin-332-rich extracellular matrix prepared from the human SCC-25 cell line, as we have described previously [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>]. Cells were co-transfected with the above luciferase reporter plasmids and a TK promoter/<italic>Renilla</italic> luciferase internal control plasmid (pRLTK, Promega) at a 50:1 ratio using lipofectamine. After 24 hours, cell lysates were collected and luciferase activity was measured using the Dual-Luciferase Reporter Assay Kit (Promega) and a TD-20/20 luminometer (Turner Designs). For each sample, expression from the experimental luciferase plasmid was normalized to that from pRLTK to control for differences in transfection efficiency, and relative luciferase activity was plotted as described in the <xref rid="pone.0119539.g001" ref-type="fig">Fig. 1</xref> legend.</p><fig id="pone.0119539.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119539.g001</object-id><label>Fig 1</label><caption><title>Influence of 3&#x02019;-UTR AREs on luciferase reporter expression in MK cells that express or lack integrin &#x003b1;3&#x003b2;1.</title><p>(A) Schematic of CMV promoter-driven luciferase reporter genes containing pentamers that encode either consensus AU-rich ARE sequences or control GC-rich sequences within the 3&#x02019;-UTR of the mRNA. Reporter plasmids were transfected into &#x003b1;3-expressing MK+/+ cells or &#x003b1;3-null MK&#x02212;/&#x02212; cells, and experimental luciferase signals were normalized to that for a co-transfected <italic>Renilla</italic> luciferase control plasmid (pRLTK). Graph shows luciferase activity from the AU-rich reporter relative to that from the GC-rich reporter. (B) Schematic of MMP-9 promoter-driven luciferase reporter genes containing either the MMP-9 3&#x02019;-UTR or the SV40 poly(A) signal downstream of luciferase coding sequences. MK+/+ cells or MK&#x02212;/&#x02212; cells were co-transfected with reporter and control plasmids as in (A). Graph shows luciferase activity from the MMP-9 3&#x02019;-UTR reporter relative to that from the SV40 poly(A) reporter. For (A) and (B), MK cells were seeded onto LN-332-rich ECM and transfected for 24 hours, then luciferase expression was assayed as described in the Materials and Methods. Data are the mean of three independent experiments +/- s.e.m.</p></caption><graphic xlink:href="pone.0119539.g001"/></fig></sec><sec id="sec005"><title>Adenoviral infection</title><p>Adenovirus expressing a tamoxifen-inducible form of Raf-1 (DRaf-1:ER*) was kindly provided by Dr. Kevin Pumiglia (Albany Medical College), and consisted of a BamH1 fragment encoding tamoxifen-inducible Raf-1 [<xref rid="pone.0119539.ref031" ref-type="bibr">31</xref>] cloned into a Bgl II site in pAdTrack-CMV. Adenoviruses were generated essentially as described previously [<xref rid="pone.0119539.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0119539.ref033" ref-type="bibr">33</xref>]. MK cells cultured on collagen coated 6-well plates were infected with adenoviral particles plus antennapedia peptide (Anaspec, Fremont, CA) for 24 hours with or without 1&#x003bc;M 4-OH tamoxifen, then cultured for an additional 24 hours (+ or &#x02212; tamoxifen) prior to preparing RNA or cell lysates, as described below.</p></sec><sec id="sec006"><title>Cloning of MMP-9 3&#x02019;-UTR</title><p>A truncated variant of the MMP-9 mRNA that lacks the AREs was cloned from MK+/+ cells using the 3&#x02019;-RACE System (Invitrogen, Carlsbad, CA) with a forward primer (<xref rid="pone.0119539.g002" ref-type="fig">Fig. 2A</xref>, P1) that targets the coding region upstream of the stop codon (5&#x02019;-GTCTGGATAAGTTGGGTCTAG-3&#x02019;), and a reverse adaptor primer (<xref rid="pone.0119539.g002" ref-type="fig">Fig. 2A</xref>, P2; supplied with the kit) that targets the polyadenylated tails of mRNA transcripts. A PCR product of &#x0223c;600 bp was amplified from MK+/+ cells, cloned into the pGEM-T Easy Vector (Promega), and sequenced.</p><fig id="pone.0119539.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119539.g002</object-id><label>Fig 2</label><caption><title>Keratinocytes express a truncated MMP-9 mRNA variant that lacks 3&#x02019;-UTR AREs.</title><p>(A) Schematic of MMP-9 mRNA 3&#x02019;-UTR variants. Sequences corresponding to alternative poly(A) signals (<italic>black triangles)</italic> flank ARE motifs within the long variant (<italic>white boxes</italic>, <italic>1&#x02013;4</italic>). 5&#x02019;-UTR (<italic>white</italic>) and protein coding regions (<italic>blue</italic>) are also shown (not to scale). An Xba1 site (for reference) and approximate positions of <italic>P1</italic> and <italic>P2</italic> cloning primers (not to scale) are indicated. (B) 3&#x02019;-RACE was used to PCR-amplify cDNAs corresponding to the 3&#x02019;-UTR of the MMP-9 mRNA. The cDNA sequence of a &#x0201c;short&#x0201d; 3&#x02019;-UTR variant that was amplified from MK+/+ cells (<italic>blue</italic>) is aligned against the known cDNA sequence of the &#x0201c;long&#x0201d; 3&#x02019;-UTR variant of murine MMP-9 mRNA (<italic>black</italic>) (GenBank: BC046991.1). The stop codon (TGA) adjacent to the 3&#x02019;-UTR is boxed; the position of polyadenylation for each variant is indicated by the red poly(A); poly(A) signals (AATAAA) are overlined in green (two AATAAA motifs occur near the end of the long variant); four canonical AREs are present only in the long variant and are overlined in purple and numbered 1&#x02013;4.</p></caption><graphic xlink:href="pone.0119539.g002"/></fig></sec><sec id="sec007"><title>RNase protection assay</title><p>Total RNA was isolated from MK cells using the RNeasy Plus isolation kit (Qiagen,Valencia, CA). RNA was reverse transcribed using the 3&#x02019;-RACE System (Invitrogen). PCR was performed using Sigma Ready Mix without RedTaq (Sigma, St Louis MO) with a forward primer (5&#x02019;-CAGGAGTCTGGATAAGTTGG-3&#x02019;) and the AUAP (abridged universal amplification primer) that binds an adaptor sequence added to the polyA(+) tail from the 3&#x02019;-RACE kit (5&#x02019;-GGCCACGCGTCGACTAGTAC-3&#x02019;). PCR conditions were as follows: 94&#x000b0;C hot start for 3 minutes; denaturation at 94&#x000b0;C for 60 seconds; annealing at 50&#x000b0;C for 60 seconds; extension at 72&#x000b0;C for 120 seconds; 35 amplification cycles with a final extension of 120 seconds at 72&#x000b0;C. Equal quantities of PCR product were assayed using the Ribonuclease Protection Assay kit (Ambion, Grand Island, NY) according to the manufacturer&#x02019;s protocol. RNA probes were transcribed with biotin-16-UTP using the MAXIscript <italic>in vitro</italic> transcription kit (Ambion). Probes were designed to hybridize either upstream of the proximal poly(A) signal within the 3&#x02019;-UTR of mouse MMP-9 (control probe, protects 202 nucleotides) or spanning the proximal poly(A) signal (short/long probe, detects 401 nucleotides for long variant, or 241 nucleotides for short variant). Products were electrophoresed on a 5% denaturing urea gel and transferred to Brightstar-Plus membranes (Ambion) using a semi-dry transfer apparatus (Biorad, Hercules CA), at 200 mAmps for 1 hour. Membranes were then UV-crosslinked and assayed using the Brightstart Biodect system for nonisotopic detection (Ambion). Signals were quantified from at least three independent experiments. The MMP-9 mRNA long variant was quantified as a proportion of total MMP-9 mRNA (i.e., summation of the short and long variants), normalized to the daily mean to account for variability by day. For each experiment, data were normalized further by dividing each value by the average value for the control.</p></sec><sec id="sec008"><title>Western blot</title><p>Total cell lysates were prepared in non-reducing Cell Lysis Buffer (Cell Signaling Technology, Beverly, MA), and protein concentrations were quantified using the BCA Protein Assay kit (Pierce, Rockford, IL). Equal protein concentrations were subjected to 10% SDS-PAGE, transferred to nitrocellulose membranes, and blocked with 5% BSA/TBST. Rabbit polyclonal antisera against the integrin &#x003b1;3 subunit [<xref rid="pone.0119539.ref034" ref-type="bibr">34</xref>], p-ERK (Cell Signaling Technology), ERK (Santa Cruz Biotechnology, Santa Cruz, CA), and ER (Santa Cruz, Santa Cruz, CA) were used at 1:1000 dilution, followed by horse-radish peroxidase-conjugated goat anti-rabbit IgG at 1:2000 dilution (Cell Signaling Technology). Chemiluminescence was performed using the SuperSignal kit (ThermoScientific, Rockford, IL).</p></sec><sec id="sec009"><title>Ethics Statement</title><p>Animal experiments were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at Albany Medical College (Protocol Number: 12-06004). Euthanasia was performed using carbon dioxide inhalation in a closed chamber followed by death verification by decapitation.</p></sec></sec><sec sec-type="results" id="sec010"><title>Results</title><sec id="sec011"><title>mRNA destabilizing AU-rich elements function independently of integrin &#x003b1;3&#x003b2;1</title><p>We previously demonstrated that absence of integrin &#x003b1;3&#x003b2;1 in immortalized mouse keratinocytes (MK cells) leads to increased turnover of the MMP-9 mRNA transcript, indicating an important role for this integrin in controlling MMP-9 mRNA stability [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>]. The 3&#x02019;-UTR of the full-length MMP-9 mRNA transcript contains several canonical AREs [<xref rid="pone.0119539.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0119539.ref035" ref-type="bibr">35</xref>], and previous studies in renal mesangial cells have demonstrated that nitrous oxide and interleukin-1&#x003b2; can alter MMP-9 mRNA stability through regulation of these AREs [<xref rid="pone.0119539.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0119539.ref015" ref-type="bibr">15</xref>]. To determine whether &#x003b1;3&#x003b2;1 regulates ARE function, we employed a previously established luciferase reporter assay for assessing ARE-mediated effects on mRNA expression [<xref rid="pone.0119539.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0119539.ref029" ref-type="bibr">29</xref>]. First, we transiently transfected either wild type MK cells (MK+/+ cells) or &#x003b1;3-null MK cells (MK&#x02212;/&#x02212; cells) with reporter plasmids in which the CMV promoter drives expression of the firefly luciferase gene to generate a mRNA transcript that harbors pentamers of either consensus ARE sequences or control GC-rich sequences within the 3&#x02019;-UTR (<xref rid="pone.0119539.g001" ref-type="fig">Fig. 1A</xref>). Of note, luciferase reporter signals from the control GC-rich plasmid (normalized to a co-transfected <italic>Renilla</italic> luciferase plasmid) were comparable between MK+/+ cells and MK&#x02212;/&#x02212; cells, indicating similar levels of CMV promoter activity in these cells. Thus, any differences in normalized luciferase expression between the AU-rich and GC-rich reporter genes can be attributed to the presence or absence of AREs within the 3&#x02019;-UTR [<xref rid="pone.0119539.ref029" ref-type="bibr">29</xref>]. For these experiments cells were cultured on laminin-332-rich extracellular matrix, on which they exhibit &#x003b1;3&#x003b2;1-dependent stability of endogenous MMP-9 mRNA [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>]. Interestingly, the AU-rich pentamer conferred reduced luciferase expression compared to the GC-rich pentamer in both MK+/+ cells and MK&#x02212;/&#x02212; cells (<xref rid="pone.0119539.g001" ref-type="fig">Fig. 1A</xref>, graphs), indicating that ARE-mediated reduction of the reporter mRNA occurs independently of &#x003b1;3&#x003b2;1 expression.</p><p>To test the possibility that context of the AREs within the MMP-9 3&#x02019;-UTR is important for &#x003b1;3&#x003b2;1-dependent function, we performed similar experiments using a separate set of luciferase reporter constructs in which either the MMP-9 3&#x02019;-UTR that encompass the AREs, or the SV40 3&#x02019;-UTR as a control, was inserted downstream of the reporter gene open reading frame (<xref rid="pone.0119539.g001" ref-type="fig">Fig. 1B</xref>) [<xref rid="pone.0119539.ref030" ref-type="bibr">30</xref>]. Again, normalized luciferase signals from the SV40 3&#x02019;-UTR control plasmid were within &#x0223c;1.6-fold between MK+/+ cells and MK&#x02212;/&#x02212; cells, indicating similar MMP-9 promoter activity in these cells as we described previously [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>]. However, we observed that the MMP-9 3&#x02019;-UTR conferred reduced luciferase reporter expression, compared to the SV40 3&#x02019;-UTR control, in both MK+/+ cells and MK&#x02212;/&#x02212; cells (<xref rid="pone.0119539.g001" ref-type="fig">Fig. 1B</xref>, graphs). Taken together, our results suggest that ARE function in MK cells, either in isolation or within the context of the MMP-9 3&#x02019;-UTR, is not altered by the presence or absence of &#x003b1;3&#x003b2;1.</p></sec><sec id="sec012"><title>Keratinocytes express a truncated variant of the MMP-9 mRNA that lacks AREs in the 3&#x02019;-UTR</title><p>A review of the literature regarding the cloning and characterization of MMP-9 from various cell types and species revealed the existence of 3&#x02019;-UTR variants of the MMP-9 mRNA that either contain or lack AREs [<xref rid="pone.0119539.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0119539.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0119539.ref035" ref-type="bibr">35</xref>&#x02013;<xref rid="pone.0119539.ref038" ref-type="bibr">38</xref>]. One early study in which MMP-9 cDNAs were cloned from cutaneous wounds in rats identified two alternative poly(A) signals (AATAAA) in the MMP-9 gene that flank the sequences encoding several AREs in the 3&#x02019;-UTR [<xref rid="pone.0119539.ref036" ref-type="bibr">36</xref>]. Similarly, examination of the full-length murine MMP-9 cDNA revealed a potential alternative poly(A) signal that lies upstream of four canonical AREs (shown schematically in <xref rid="pone.0119539.g002" ref-type="fig">Fig. 2A</xref>, and indicated in the cDNA sequence of the full-length 3&#x02019;-UTR in <xref rid="pone.0119539.g002" ref-type="fig">Fig. 2B</xref>), consistent with a previous report that the MMP-9 gene undergoes APA in murine macrophages [<xref rid="pone.0119539.ref027" ref-type="bibr">27</xref>]. Taken together, these observations suggest that MMP-9 mRNA stability is controlled through generation of transcript variants that contain or lack AREs in the 3&#x02019;-UTR through alternative use of distal and proximal poly(A) signals, respectively, that flank these elements.</p><p>The potential for APA to generate MMP-9 mRNA variants (<xref rid="pone.0119539.g002" ref-type="fig">Fig. 2</xref>), combined with our observations that &#x003b1;3&#x003b2;1 expression did not alter ARE function in the reporter assays (<xref rid="pone.0119539.g001" ref-type="fig">Fig. 1</xref>), prompted us to explore whether &#x003b1;3&#x003b2;1 promotes use of the proximal poly(A) signal thereby excluding AREs from the 3&#x02019;-UTR. This model predicts that expression of a shorter variant of the MMP-9 mRNA should be enriched in &#x003b1;3&#x003b2;1-expressing MK+/+ cells, compared with &#x003b1;3&#x003b2;1-deficient MK&#x02212;/&#x02212; cells. This prediction was confirmed by 3&#x02019;-RACE using a forward primer that targets the MMP-9 coding region just upstream of the stop codon (<xref rid="pone.0119539.g002" ref-type="fig">Fig. 2A</xref>, P1) and a reverse adaptor primer that targets the polyA(+) tails of mRNAs (<xref rid="pone.0119539.g002" ref-type="fig">Fig. 2A</xref>, P2; see <xref rid="sec002" ref-type="sec">Materials and Methods</xref> for details). This primer pair is therefore designed to amplify either the full-length or 3&#x02019;-UTR truncations of the MMP-9 mRNA transcript. Using this approach, we isolated a cDNA from MK+/+ cells that corresponds to a &#x0201c;short&#x0201d; variant of the MMP-9 mRNA. Indeed, alignment of this cloned sequence with the published, full-length 3&#x02019;-UTR cDNA sequence for murine MMP-9 (i.e. the &#x0201c;long&#x0201d; variant) confirmed that it represents a truncated version of the MMP-9 mRNA transcript that lacks all of the canonical AREs (<xref rid="pone.0119539.g002" ref-type="fig">Fig. 2B</xref>). Interestingly, we failed to amplify this short MMP-9 mRNA variant in MK&#x02212;/&#x02212; cells using identical 3&#x02019;-RACE conditions, supporting our hypothesis that this variant is enriched in cells that express &#x003b1;3&#x003b2;1.</p></sec><sec id="sec013"><title>Expression of integrin &#x003b1;3&#x003b2;1 controls the generation of MMP-9 mRNA 3&#x02019;-UTR variants through use of alternative poly(A) sites that determine ARE content</title><p>To directly test our hypothesis that &#x003b1;3&#x003b2;1 influences APA that determines inclusion or exclusion of 3&#x02019;-UTR AREs, we developed an RNase protection assay (RPA) to detect use of the upstream poly(A) signal and assess the relative amounts of short and long mRNA variants in MK cells that express or lack &#x003b1;3&#x003b2;1. For these experiments, we generated a biotin-UTP-labeled RNA probe that spans sequences corresponding to the proximal poly(A) site and can therefore distinguish use of the proximal and distal poly(A) signals. As depicted schematically in <xref rid="pone.0119539.g003" ref-type="fig">Fig. 3A</xref>, this &#x0201c;short/long&#x0201d; probe is only partially protected by a mRNA that is generated through use of the proximal poly(A) signal (indicated by a 241 nucleotide product), but it is fully protected if the proximal poly(A) signal is skipped (indicated by a 401 nucleotide product). As a control, we generated an RNA probe corresponding to a 3&#x02019;-UTR sequence upstream of the proximal poly(A) signal that is fully protected by either the long or short mRNA variant (indicated by a 202 nucleotide product). Due to very low levels of endogenous MMP-9 mRNA, it was necessary to perform RT-PCR to amplify cDNA products corresponding to the 3&#x02019;-UTR mRNA variants prior to their detection by RPA (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref>). RPA using the control probe revealed that total MMP-9 mRNA levels were markedly reduced in &#x003b1;3-null MK&#x02212;/&#x02212; cells compared with wild type MK+/+ cells, but were restored in MK&#x02212;/&#x02212; cells stably transfected with human &#x003b1;3 (MK&#x02212;/&#x02212;: h&#x003b1;3) (<xref rid="pone.0119539.g003" ref-type="fig">Fig. 3B</xref>), consistent with our previous studies showing &#x003b1;3&#x003b2;1-dependent MMP-9 mRNA expression [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>]. RPA using the short/long probe detected the short and long mRNA variants in MK cells; as expected, total MMP-9 mRNA (i.e., the sum of short plus long variants) was markedly lower in &#x003b1;3-null MK&#x02212;/&#x02212; cells compared with &#x003b1;3&#x003b2;1-expressing MK cells (<xref rid="pone.0119539.g003" ref-type="fig">Fig. 3B</xref>). Importantly, however, the relative amount of the long variant as a proportion of the total MMP-9 mRNA was higher in MK&#x02212;/&#x02212; cells compared with either MK+/+ or MK&#x02212;/&#x02212;: h&#x003b1;3 cells (<xref rid="pone.0119539.g003" ref-type="fig">Fig. 3C</xref>). This trend, combined with reduced overall levels of MMP-9 mRNA in MK&#x02212;/&#x02212; cells, indicates a shift towards preferential use of the distal poly(A) site when &#x003b1;3&#x003b2;1 is not expressed, presumably leading to a less stable mRNA transcript. These findings suggest that &#x003b1;3&#x003b2;1 promotes use of the proximal poly(A) site to generate the short mRNA variant, leading to exclusion of the 3&#x02019;-UTR AREs and enhanced stability of the MMP-9 mRNA transcript.</p><fig id="pone.0119539.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119539.g003</object-id><label>Fig 3</label><caption><title>Integrin &#x003b1;3&#x003b2;1 expression enhances MMP-9 mRNA and promotes use of the proximal poly(A) signal.</title><p>(A) Schematic of RPA probes and their alignment with protected regions of long and short variants of the MMP-9 mRNA. The control RPA probe that corresponds to common 3&#x02019;-UTR sequences upstream of the proximal poly(A) signal is fully protected by either mRNA variant, while the short/long RPA probe that spans the proximal poly(A) signal is not fully protected by the short mRNA variant (indicated by the dashed portion). Lengths of protected regions are indicated in nucleotides (<italic>n</italic>). (B) RPA was performed as described in the Materials and Methods using the control or short/long probes to assess relative expression of MMP-9 mRNA variants in MK+/+ cells, MK&#x02212;/&#x02212; cells, or MK&#x02212;/&#x02212;: h&#x003b1;3 cells. Control reactions included probe only in the presence (<italic>probe</italic>, <italic>+RNase</italic>) or absence of RNase (<italic>probe,-RNase</italic>). M, size markers in nucleotides (<italic>n</italic>); lengths of protected probes are indicated to the right. (C) Signal quantification from three independent RPA experiments (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref>) reveals that the MMP-9 mRNA long variant constitutes a higher proportion of the total MMP-9 mRNA expressed in MK&#x02212;/&#x02212; cells, compared with &#x003b1;3-expressing MK+/+ cells or MK&#x02212;/&#x02212;: h&#x003b1;3 cells. Data are mean &#x000b1; s.e.m. (n = 3); all values were normalized through dividing by the average for the control (MK+/+). *P&#x0003c;0.05, one-way ANOVA, post-test Tukeys multiple comparison.</p></caption><graphic xlink:href="pone.0119539.g003"/></fig></sec><sec id="sec014"><title>&#x003b1;3&#x003b2;1-dependent expression of the short MMP-9 mRNA variant is acquired by immortalized keratinocytes</title><p>We previously demonstrated that &#x003b1;3&#x003b2;1-dependent regulation of MMP-9 expression is acquired during keratinocyte immortalization, suggesting that this regulation may have important roles in epidermal tumorigenesis [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>]. To determine if &#x003b1;3&#x003b2;1-dependent APA was similarly acquired by immortalized MK cells, we isolated primary keratinocytes from neonatal mice that either express &#x003b1;3&#x003b2;1 (control mice) or lack &#x003b1;3&#x003b2;1 in the epidermis (&#x003b1;3eKO mice), as described previously [<xref rid="pone.0119539.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0119539.ref039" ref-type="bibr">39</xref>], then performed RPA to evaluate expression of MMP-9 mRNA variants. We observed that expression of both the long and short mRNA variants was similar between &#x003b1;3-expressing and &#x003b1;3-null primary keratinocytes (<xref rid="pone.0119539.g004" ref-type="fig">Fig. 4</xref>), suggesting that &#x003b1;3&#x003b2;1-dependent MMP-9 mRNA stability in immortalized keratinocytes is due at least partly to the acquisition of &#x003b1;3&#x003b2;1-dependent APA. Interestingly, the long mRNA variant constituted a large proportion of the total MMP-9 mRNA in primary keratinocytes (<xref rid="pone.0119539.g004" ref-type="fig">Fig. 4B</xref>), in contrast with immortalized MK+/+ cells which expressed primarily the short variant (<xref rid="pone.0119539.g003" ref-type="fig">Fig. 3B</xref>). Although the significance of this difference is not yet clear, it suggests that primary cells from neonatal mice preferentially utilize the distal poly(A) signal. Alternatively, or in addition, the ARE-containing long mRNA variant may be more stable in primary keratinocytes than it is in immortalized MK cells.</p><fig id="pone.0119539.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119539.g004</object-id><label>Fig 4</label><caption><title>MMP-9 mRNA variant expression is not &#x003b1;3&#x003b2;1-dependent in non-immortalized, primary keratinocytes.</title><p>(A) Western blot of lysates from representative &#x003b1;3-expressing (<italic>&#x003b1;3+</italic>) and &#x003b1;3-null (<italic>&#x003b1;3&#x02212;</italic>) primary keratinocytes with antiserum against the integrin &#x003b1;3 subunit, or ERK as a loading control; molecular weights are indicated (kDa). (B) Corresponding RPA of primary keratinocytes using the short/long probe to distinguish MMP-9 mRNA variants. Results shown in (A) and (B) are for two representative mice of each genotype. (C) RPA quantification (performed as in <xref rid="pone.0119539.g003" ref-type="fig">Fig. 3</xref>) reveals no significant difference in relative expression of the MMP-9 mRNA long variant between &#x003b1;3-expressing and &#x003b1;3-null primary keratinocytes. Data are mean &#x000b1; s.e.m. (&#x003b1;3+ keratinocytes, n = 10; &#x003b1;3&#x02212; keratinocytes, n = 17); all values were normalized through dividing by the average for the control (&#x003b1;3+). Not significant (ns), Student&#x02019;s two-tailed t-test.</p></caption><graphic xlink:href="pone.0119539.g004"/></fig></sec><sec id="sec015"><title>&#x003b1;3&#x003b2;1 promotes APA of the MMP-9 mRNA through a MEK/ERK signaling pathway</title><p>Previous reports have shown that sustained signaling through the MEK/ERK pathway promotes MMP-9 expression [<xref rid="pone.0119539.ref040" ref-type="bibr">40</xref>, <xref rid="pone.0119539.ref041" ref-type="bibr">41</xref>]. In earlier studies we observed that &#x003b1;3&#x003b2;1 in MK cells both activates MEK/ERK signaling [<xref rid="pone.0119539.ref042" ref-type="bibr">42</xref>] and induces MMP-9 expression in a MEK/ERK-dependent manner [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>], prompting us to test whether MEK/ERK signaling is involved in &#x003b1;3&#x003b2;1-dependent selection of the proximal MMP-9 poly(A) site. &#x003b1;3&#x003b2;1-expressing MK+/+ cells were treated for 24 hours with the MEK1 inhibitor U0126 (10 &#x003bc;M) to inhibit activation of ERK-1/2, or with DMSO as a control, then RPA was performed to compare relative amounts of the short and long MMP-9 mRNA variants. Inhibition of MEK/ERK signaling (<xref rid="pone.0119539.g005" ref-type="fig">Fig. 5A</xref>) caused a statistically significant increase in the long MMP-9 mRNA variant (<xref rid="pone.0119539.g005" ref-type="fig">Fig. 5B</xref>). Interestingly, treatment of &#x003b1;3-null MK&#x02212;/&#x02212; cells with U0126 also enhanced the long MMP-9 mRNA variant, indicating that inhibiting residual ERK signaling observed in these cells [<xref rid="pone.0119539.ref042" ref-type="bibr">42</xref>] similarly reduces proximal poly(A) site selection.</p><fig id="pone.0119539.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119539.g005</object-id><label>Fig 5</label><caption><title>Inhibition of MEK/ERK signaling in &#x003b1;3&#x003b2;1-expressing MK cells increases relative expression of the long MMP-9 mRNA variant.</title><p>(A) Representative western blot showing inhibition of phospho-ERK (<italic>pERK</italic>) with U0126 compound in MK+/+ cells, compared with DMSO control; <italic>ERK</italic>, total ERK; positions of molecular weight markers are indicated at right (kDa). (B) Quantification of RPA (performed as in <xref rid="pone.0119539.g003" ref-type="fig">Fig. 3</xref>) showing the effects of ERK inhibition in MK+/+ cells on the relative amount of the long MMP-9 mRNA variant. Data are mean &#x000b1; s.e.m. (n = 6); all values were normalized through dividing by the average for the control (DMSO). *P&#x0003c;0.05, Student&#x02019;s two-tailed t-test.</p></caption><graphic xlink:href="pone.0119539.g005"/></fig><p>To test if enhanced ERK signaling can induce expression of the short MMP-9 mRNA variant in the absence of &#x003b1;3&#x003b2;1, we transduced &#x003b1;3-null MK&#x02212;/&#x02212; cells with an adenovirus that expresses a tamoxifen-inducible form of Raf-1 (DRaf-1:ER*) to activate the MEK/ERK pathway, as described [<xref rid="pone.0119539.ref031" ref-type="bibr">31</xref>]. While basal expression of DRaf-1:ER* in the absence of tamoxifen slightly induced ERK phosphorylation in MK&#x02212;/&#x02212; cells, tamoxifen treatment of transduced cells caused robust ERK activation (<xref rid="pone.0119539.g006" ref-type="fig">Fig. 6A</xref>). RPA of these cells revealed an ERK-mediated increase in both the long and short MMP-9 mRNA variants (<xref rid="pone.0119539.g006" ref-type="fig">Fig. 6B</xref>), which could reflect combined inductive effects of ERK signaling on MMP-9 gene transcription and mRNA stability of the ARE-containing long variant (visible in the longer exposure of <xref rid="pone.0119539.g006" ref-type="fig">Fig. 6B</xref>). Interestingly, however, we observed that the short mRNA variant was induced to a much higher level than the long mRNA variant (<xref rid="pone.0119539.g006" ref-type="fig">Fig. 6B</xref>). This pattern of MMP-9 mRNA variants resembles that seen in &#x003b1;3&#x003b2;1-expressing MK cells (see <xref rid="pone.0119539.g003" ref-type="fig">Fig. 3</xref>) and suggests that induction of MMP-9 mRNA in response to Raf-1/MEK/ERK signaling occurs partly through a shift towards generation of the short mRNA. Taken together with our previous studies [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0119539.ref042" ref-type="bibr">42</xref>], results in Figs. <xref rid="pone.0119539.g005" ref-type="fig">5</xref> and <xref rid="pone.0119539.g006" ref-type="fig">6</xref> suggest that &#x003b1;3&#x003b2;1 signaling through a MEK/ERK pathway enhances MMP-9 mRNA expression in part by promoting use of the proximal poly(A) signal, leading to generation and subsequent accumulation of the more stable short mRNA variant.</p><fig id="pone.0119539.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119539.g006</object-id><label>Fig 6</label><caption><title>Raf-1-mediated activation of MEK/ERK in &#x003b1;3-null MK cells induces expression of the short MMP-9 mRNA variant.</title><p>MK&#x02212;/&#x02212; cells were left uninfected (<italic>ctrl</italic>) or infected with adenovirus expressing a tamoxifen-inducible form of Raf-1 (<italic>DRaf-1</italic>:<italic>ER*</italic>) in the absence (<italic>&#x02212;TMX</italic>) or presence (<italic>+TMX</italic>) of 1 &#x003bc;M tamoxifen. (A) Western blot showing that tamoxifen induction of DRaf-1:ER* leads to enhanced ERK phosphorylation (<italic>pERK</italic>); the latter blot was stripped and reprobed for total ERK (<italic>ERK</italic>); <italic>ns</italic>, non-specific band; positions of molecular weight markers are indicated at right (kDa). (B) RPA showing the effects of basal or tamoxifen-induced Raf-1 on expression of MMP-9 mRNA variants. Two different exposures of the same membrane are shown. Lengths of protected probe are indicated as in <xref rid="pone.0119539.g003" ref-type="fig">Fig. 3</xref>. Representative results are shown, n = 3.</p></caption><graphic xlink:href="pone.0119539.g006"/></fig></sec></sec><sec sec-type="conclusions" id="sec016"><title>Discussion</title><p>Alternative poly(A) site usage has emerged in recent years as an important mechanism for regulating the 3&#x02019;-UTR content of mRNA transcripts, including the inclusion or exclusion of AREs that control mRNA stability (reviewed in [<xref rid="pone.0119539.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0119539.ref043" ref-type="bibr">43</xref>]). Although some integrins have long been known to regulate gene expression through mRNA stability [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0119539.ref021" ref-type="bibr">21</xref>], roles for integrins in controlling APA as a potential mechanism to regulate mRNA stability have been unexplored. In the current study, we cloned a short variant of the MMP-9 mRNA from immortalized keratinocytes that is generated through APA and lacks the 3&#x02019;-UTR AREs. Moreover, we used an RPA approach to demonstrate that the MMP-9 mRNA pool from cells that express integrin &#x003b1;3&#x003b2;1 is enriched for the short variant, compared with &#x003b1;3-null cells, indicating a novel role for &#x003b1;3&#x003b2;1 in promoting APA that determines the exclusion of AREs from the 3&#x02019;-UTR. These findings support a model, outlined in <xref rid="pone.0119539.g007" ref-type="fig">Fig. 7</xref>, wherein &#x003b1;3&#x003b2;1-mediated MMP-9 mRNA stability that we described previously [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>] is controlled through generation of a short 3&#x02019;-UTR variant that lacks AREs, due to preferential usage of a proximal poly(A) signal that lies upstream of these elements. Thus, our study provides initial evidence that an integrin can regulate poly(A) site selection, representing a new mode of integrin-mediated gene regulation. It will be interesting in future studies to determine whether other integrins can similarly regulate APA, or whether this regulation is specific to integrin &#x003b1;3&#x003b2;1.</p><fig id="pone.0119539.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0119539.g007</object-id><label>Fig 7</label><caption><title>Model depicting &#x003b1;3&#x003b2;1-dependent alternative polyadenylation of the MMP-9 mRNA.</title><p>(A) Integrin &#x003b1;3&#x003b2;1 activates a MEK/ERK signaling pathway that promotes selection of the proximal polyadenylation site (polyA #1) within the MMP-9 gene, thereby generating the short, more stable mRNA transcript and subsequent synthesis of MMP-9 protein. (B) In the absence of &#x003b1;3&#x003b2;1, MEK/ERK signaling is diminished and polyadenylation defaults to the distal polyadenylation site (polyA #2), thereby generating the long, ARE-containing transcript that is subject to mRNA degradation. Positions of the stop codon, AREs (yellow boxes), poly(A) signals, and poly(A+) tails are indicated.</p></caption><graphic xlink:href="pone.0119539.g007"/></fig><p>It has long been known that neoplastic transformation can stabilize ARE-containing mRNAs [<xref rid="pone.0119539.ref044" ref-type="bibr">44</xref>], and that increased mRNA stability has relevance to genes involved in human cancers [<xref rid="pone.0119539.ref045" ref-type="bibr">45</xref>&#x02013;<xref rid="pone.0119539.ref047" ref-type="bibr">47</xref>]. However, our current results show that ARE function was not directly altered in immortalized keratinocytes by the presence or absence of &#x003b1;3&#x003b2;1, at least in the context of exogenous ARE reporter constructs. Instead, our results support a role for &#x003b1;3&#x003b2;1 in APA as an alternate means to control mRNA stability by determining ARE content of the target transcript. These observations expand on a novel role that we recently described for &#x003b1;3&#x003b2;1 in controlling post-transcriptional mRNA processing in breast cancer cells, where we showed that RNAi-mediated suppression of &#x003b1;3 promotes alternative splicing of the cyclooxygenase-2 (COX-2) mRNA that targets it for nonsense-mediated decay [<xref rid="pone.0119539.ref048" ref-type="bibr">48</xref>]. Together, these studies point towards a broad role for &#x003b1;3&#x003b2;1 in controlling mRNA stability by regulating the sequence content of target transcripts.</p><p>We previously showed that &#x003b1;3&#x003b2;1 in MK cells promotes both MEK/ERK signaling [<xref rid="pone.0119539.ref042" ref-type="bibr">42</xref>] and MMP-9 gene expression [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>]. Here we showed that ERK signaling was both necessary in wild type MK cells (<xref rid="pone.0119539.g005" ref-type="fig">Fig. 5</xref>) and sufficient in &#x003b1;3-null MK&#x02212;/&#x02212; cells (<xref rid="pone.0119539.g006" ref-type="fig">Fig. 6</xref>) to promote expression of the short mRNA variant that is generated through selection of the proximal poly(A) site within the MMP-9 gene, suggesting that &#x003b1;3&#x003b2;1-mediated signaling through a MEK/ERK pathway controls APA of the MMP-9 mRNA. It is possible that an ERK-induced poly(A) switch occurs as a result of enhanced MMP-9 gene transcription, since generation of shorter mRNA transcripts through use of upstream poly(A) sites has been linked to enhanced transcriptional activity (see below). Activation of MEK/ERK signaling also enhanced expression of the long mRNA variant (<xref rid="pone.0119539.g006" ref-type="fig">Fig. 6</xref>), consistent with previous studies that have linked MEK/ERK signaling to ARE-mediated mRNA stability [<xref rid="pone.0119539.ref049" ref-type="bibr">49</xref>, <xref rid="pone.0119539.ref050" ref-type="bibr">50</xref>]. Interestingly, signaling via MEK/ERK has been shown to increase MMP-9 production in a range of cancer types, including SCC [<xref rid="pone.0119539.ref051" ref-type="bibr">51</xref>], chondrosarcoma [<xref rid="pone.0119539.ref052" ref-type="bibr">52</xref>], breast cancer [<xref rid="pone.0119539.ref053" ref-type="bibr">53</xref>], fibrosarcoma [<xref rid="pone.0119539.ref054" ref-type="bibr">54</xref>], prostate cancer [<xref rid="pone.0119539.ref055" ref-type="bibr">55</xref>], osteosarcoma [<xref rid="pone.0119539.ref056" ref-type="bibr">56</xref>], and glioma [<xref rid="pone.0119539.ref057" ref-type="bibr">57</xref>], raising the possibility that MEK/ERK-mediated APA plays a role in controlling MMP-9 expression in different types of tumors, possibly in response to different stimuli.</p><p>APA is a widely used mechanism of post-transcriptional gene regulation during both normal and pathological tissue remodeling processes [<xref rid="pone.0119539.ref022" ref-type="bibr">22</xref>, <xref rid="pone.0119539.ref058" ref-type="bibr">58</xref>]. Generation of longer ARE-containing mRNAs may be important for cellular adaptations that require more rapid or regulated changes in MMP-9 mRNA turnover. Indeed, progressive lengthening of 3'-UTRs through APA occurs during mouse embryonic development, perhaps reflecting a need for rapid changes in gene expression that are achieved through incorporation of AREs into the 3&#x02019;-UTR [<xref rid="pone.0119539.ref059" ref-type="bibr">59</xref>]. On the other hand, reduced 3'-UTR length accompanied by enhanced mRNA stability is often associated with increased cell proliferation [<xref rid="pone.0119539.ref060" ref-type="bibr">60</xref>] and has been linked to oncogene activation in cancer cells [<xref rid="pone.0119539.ref025" ref-type="bibr">25</xref>]. Consistently, we observed that the long MMP-9 mRNA variant was present at a relatively higher level than the short variant in neonatal primary keratinocytes (<xref rid="pone.0119539.g004" ref-type="fig">Fig. 4</xref>), while the short mRNA variant was by far the more abundant form in immortalized MK cells that express &#x003b1;3&#x003b2;1 (<xref rid="pone.0119539.g003" ref-type="fig">Fig. 3</xref>). These different patterns might reflect preferential use of the distal poly(A) site during perinatal development, and an &#x003b1;3&#x003b2;1-dependent switch towards use of the proximal poly(A) site in immortalized cells. Alternatively, or in addition, the long ARE-containing variant may be more stable in neonatal keratinocytes. Further experiments will be required to distinguish these possibilities.</p><p>Genes that are regulated through APA fall into a wide range of functional groups and include transcriptional regulators, intracellular enzymes, extracellular proteases, growth factors and cytokines, integrins, and even RBPs that control ARE-mediated mRNA stability [<xref rid="pone.0119539.ref027" ref-type="bibr">27</xref>, <xref rid="pone.0119539.ref061" ref-type="bibr">61</xref>&#x02013;<xref rid="pone.0119539.ref065" ref-type="bibr">65</xref>]. Indeed, one report showed that HuR regulates APA of its own gene to promote ARE inclusion and subsequent down-regulation of HuR mRNA, indicating a negative feedback loop through which HuR auto-regulates mRNA stability [<xref rid="pone.0119539.ref062" ref-type="bibr">62</xref>]. Although mechanisms that control APA remain unclear, analyses of both the human and mouse transcriptomes indicated that shorter 3&#x02019;-UTR variants are relatively more abundant for genes that are expressed at high levels, while longer 3&#x02019;-UTR variants are relatively more abundant for genes that are expressed at low levels, suggesting that poly(A) site usage may be coupled with transcriptional activity [<xref rid="pone.0119539.ref066" ref-type="bibr">66</xref>]. Interestingly, our previous studies showed that activity of a transfected MMP-9 promoter was comparable in immortalized MK+/+ and MK&#x02212;/&#x02212; cells [<xref rid="pone.0119539.ref016" ref-type="bibr">16</xref>], but it was reduced considerably in these cells compared with non-immortalized, primary keratinocytes [<xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>]. It remains to be determined whether the endogenous MMP-9 promoter shows similar transcription patterns in primary versus immortalized cells. However, since &#x003b1;3&#x003b2;1-dependent regulation of the MMP-9 gene was acquired by immortalized keratinocytes [<xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>], it is possible that &#x003b1;3&#x003b2;1 becomes required in these cells to promote proximal poly(A) site usage as transcription is reduced, in order to maintain sufficiently high MMP-9 mRNA levels through enhanced stability.</p><p>Integrin &#x003b1;3&#x003b2;1 has important roles in promoting the growth of epidermal tumors [<xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0119539.ref067" ref-type="bibr">67</xref>]. Many pro-tumorigenic functions of &#x003b1;3&#x003b2;1 may be controlled through lateral association with the tetraspanin family member, CD151, which occurs within tetraspanin-enriched microdomains on the cell surface [<xref rid="pone.0119539.ref068" ref-type="bibr">68</xref>&#x02013;<xref rid="pone.0119539.ref070" ref-type="bibr">70</xref>]. Indeed, others have shown that CD151 promotes tumor growth and metastasis [<xref rid="pone.0119539.ref071" ref-type="bibr">71</xref>, <xref rid="pone.0119539.ref072" ref-type="bibr">72</xref>], and in some cases the CD151/&#x003b1;3&#x003b2;1 complex has been shown to regulate expression or proteolytic activity of certain MMPs [<xref rid="pone.0119539.ref073" ref-type="bibr">73</xref>, <xref rid="pone.0119539.ref074" ref-type="bibr">74</xref>]. Interestingly, CD151 can promote MMP-9 expression in some tumor cells [<xref rid="pone.0119539.ref075" ref-type="bibr">75</xref>], and RNAi-mediated suppression of CD151 in epidermal carcinoma cells led to the internalization of &#x003b1;3&#x003b2;1 accompanied by down-regulation of MMP-9 [<xref rid="pone.0119539.ref076" ref-type="bibr">76</xref>]. These previous findings raise the intriguing possibility that the CD151/&#x003b1;3&#x003b2;1 complex plays a role in the regulation of MMP-9 mRNA stability. However, it remains to be determined whether &#x003b1;3&#x003b2;1 must interact with CD151 to promote APA or stability of the MMP-9 mRNA in our keratinocyte model, and this interesting question will be the subject of future studies.</p><p>In a recent genome-wide comparison of wild type and &#x003b1;3-null keratinocytes, we showed that &#x003b1;3&#x003b2;1 regulates numerous genes with potential roles in extracellular matrix remodeling and tumor growth/progression [<xref rid="pone.0119539.ref039" ref-type="bibr">39</xref>]. Interestingly, for the majority of these genes &#x003b1;3&#x003b2;1-dependent regulation was acquired in immortalized cells (i.e., it was not observed in non-immortalized primary keratinocytes), as we had also reported for MMP-9 [<xref rid="pone.0119539.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0119539.ref009" ref-type="bibr">9</xref>]. Our current observation that &#x003b1;3&#x003b2;1-dependent APA of the MMP-9 gene was similarly associated with immortalization suggests that this mode of regulation contributes to the acquisition by immortalized cells of &#x003b1;3&#x003b2;1-dependent MMP-9 expression. Thus, &#x003b1;3&#x003b2;1-dependent APA may reflect an adaptation that occurs in tumorigenic cells to promote MMP-9 expression, thereby driving tumor growth and progression. This regulation could extend to other pro-tumorigenic/pro-angiogenic genes that are regulated by &#x003b1;3&#x003b2;1, including fibulin-2 and MRP3 in MK cells [<xref rid="pone.0119539.ref028" ref-type="bibr">28</xref>, <xref rid="pone.0119539.ref039" ref-type="bibr">39</xref>], and COX-2 in breast cancer cells [<xref rid="pone.0119539.ref048" ref-type="bibr">48</xref>], as these genes harbor potential APA sites that in some cases flank canonical AREs within the 3&#x02019;-UTR [<xref rid="pone.0119539.ref065" ref-type="bibr">65</xref>, <xref rid="pone.0119539.ref077" ref-type="bibr">77</xref>]. It will be interesting to determine whether &#x003b1;3&#x003b2;1 similarly regulates APA of these or other target genes, and if so whether this regulation is acquired by immortalized or transformed cells as it is for MMP-9. Further characterization of the pathways that control &#x003b1;3&#x003b2;1-mediated APA may reveal novel vulnerabilities that are acquired by tumor cells and can be exploited as therapeutic targets to alter cancer-promoting gene expression programs without affecting gene regulation in normal cells.</p></sec></body><back><ack><p>We thank Dr. Joan Steitz and Dr. Wolfgang Eberhardt for graciously providing luciferase reporter plasmids, and Dr. Kevin Pumiglia for the generous gift of adenovirus encoding tamoxifen-inducible DRaf-1, as well as many helpful discussions. We thank Scott Lyons for technical assistance, and Dr. Peter Vincent for assistance with statistics.</p></ack><ref-list><title>References</title><ref id="pone.0119539.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Kreidberg</surname><given-names>JA</given-names></name>
<article-title>Functions of &#x003b1;3&#x003b2;1 integrin</article-title>. <source>Curr Opin Cell Biol</source>. <year>2000</year>;<volume>12</volume>: <fpage>548</fpage>&#x02013;<lpage>553</lpage>
<object-id pub-id-type="pmid">10978888</object-id><pub-id pub-id-type="pmid">10978888</pub-id></mixed-citation></ref><ref id="pone.0119539.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>DiPersio</surname><given-names>CM</given-names></name>, <name><surname>Hodivala-Dilke</surname><given-names>KM</given-names></name>, <name><surname>Jaenisch</surname><given-names>R</given-names></name>, <name><surname>Kreidberg</surname><given-names>JA</given-names></name>, <name><surname>Hynes</surname><given-names>RO</given-names></name>
<article-title>&#x003b1;3&#x003b2;1 integrin is required for normal development of the epidermal basement membrane</article-title>. <source>J Cell Biol</source>. <year>1997</year>;<volume>137</volume>: <fpage>729</fpage>&#x02013;<lpage>742</lpage>
<object-id pub-id-type="pmid">9151677</object-id><pub-id pub-id-type="pmid">9151677</pub-id></mixed-citation></ref><ref id="pone.0119539.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Has</surname><given-names>C</given-names></name>, <name><surname>Spart&#x000e0;</surname><given-names>G</given-names></name>, <name><surname>Kiritsi</surname><given-names>D</given-names></name>, <name><surname>Weibel</surname><given-names>L</given-names></name>, <name><surname>Moeller</surname><given-names>A</given-names></name>, <name><surname>Vega-Warner</surname><given-names>V</given-names></name>, <etal>et al</etal>
<article-title>Integrin &#x003b1;3 mutations with kidney, lung, and skin disease</article-title>. <source>N Engl J Med</source>. <year>2012</year>;<volume>366</volume>: <fpage>1508</fpage>&#x02013;<lpage>1514</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1110813">10.1056/NEJMoa1110813</ext-link></comment><object-id pub-id-type="pmid">22512483</object-id><pub-id pub-id-type="pmid">22512483</pub-id></mixed-citation></ref><ref id="pone.0119539.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Longmate</surname><given-names>WM</given-names></name>, <name><surname>Monichan</surname><given-names>R</given-names></name>, <name><surname>Chu</surname><given-names>ML</given-names></name>, <name><surname>Tsuda</surname><given-names>T</given-names></name>, <name><surname>Mahoney</surname><given-names>MG</given-names></name>, <name><surname>DiPersio</surname><given-names>CM</given-names></name>
<article-title>Reduced fibulin-2 contributes to loss of basement membrane integrity and skin blistering in mice lacking integrin &#x003b1;3&#x003b2;1 in the epidermis</article-title>. <source>J Invest Dermatol</source>. <year>2014</year>;<volume>134</volume>: <fpage>1609</fpage>&#x02013;<lpage>1617</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jid.2014.10">10.1038/jid.2014.10</ext-link></comment><object-id pub-id-type="pmid">24390135</object-id><pub-id pub-id-type="pmid">24390135</pub-id></mixed-citation></ref><ref id="pone.0119539.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Subbaram</surname><given-names>S</given-names></name>, <name><surname>DiPersio</surname><given-names>CM</given-names></name>
<article-title>Integrin &#x003b1;3&#x003b2;1 as a breast cancer target</article-title>. <source>Expert Opin Ther Targets</source>. <year>2011</year>;<volume>15</volume>: <fpage>1197</fpage>&#x02013;<lpage>1210</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1517/14728222.2011.609557">10.1517/14728222.2011.609557</ext-link></comment><object-id pub-id-type="pmid">21838596</object-id><pub-id pub-id-type="pmid">21838596</pub-id></mixed-citation></ref><ref id="pone.0119539.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Tsuji</surname><given-names>T</given-names></name>
<article-title>Physiological and pathological roles of &#x003b1;3&#x003b2;1 integrin</article-title>. <source>J Membr Biol</source>. <year>2004</year>;<volume>200</volume>: <fpage>115</fpage>&#x02013;<lpage>132</lpage>
<object-id pub-id-type="pmid">15625821</object-id><pub-id pub-id-type="pmid">15625821</pub-id></mixed-citation></ref><ref id="pone.0119539.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Morini</surname><given-names>M</given-names></name>, <name><surname>Mottolese</surname><given-names>M</given-names></name>, <name><surname>Ferrari</surname><given-names>N</given-names></name>, <name><surname>Ghiorzo</surname><given-names>F</given-names></name>, <name><surname>Buglioni</surname><given-names>S</given-names></name>, <name><surname>Mortarini</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity</article-title>. <source>Int J Cancer</source>. <year>2000</year>;<volume>87</volume>: <fpage>336</fpage>&#x02013;<lpage>342</lpage>
<object-id pub-id-type="pmid">10897037</object-id><pub-id pub-id-type="pmid">10897037</pub-id></mixed-citation></ref><ref id="pone.0119539.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>DiPersio</surname><given-names>CM</given-names></name>, <name><surname>Shao</surname><given-names>M</given-names></name>, <name><surname>Di Costanzo</surname><given-names>L</given-names></name>, <name><surname>Kreidberg</surname><given-names>JA</given-names></name>, <name><surname>Hynes</surname><given-names>RO</given-names></name>
<article-title>Mouse keratinocytes immortalized with large T antigen acquire &#x003b1;3&#x003b2;1 integrin-dependent secretion of MMP-9/gelatinase B</article-title>. <source>J Cell Sci</source>. <year>2000</year>;<volume>113</volume>: <fpage>2909</fpage>&#x02013;<lpage>2921</lpage>
<object-id pub-id-type="pmid">10910775</object-id><pub-id pub-id-type="pmid">10910775</pub-id></mixed-citation></ref><ref id="pone.0119539.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Lamar</surname><given-names>JM</given-names></name>, <name><surname>Pumiglia</surname><given-names>KM</given-names></name>, <name><surname>DiPersio</surname><given-names>CM</given-names></name>
<article-title>An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion</article-title>. <source>Cancer Res</source>. <year>2008</year>;<volume>68</volume>: <fpage>7371</fpage>&#x02013;<lpage>7379</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-08-1080">10.1158/0008-5472.CAN-08-1080</ext-link></comment><object-id pub-id-type="pmid">18794124</object-id><pub-id pub-id-type="pmid">18794124</pub-id></mixed-citation></ref><ref id="pone.0119539.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>McCawley</surname><given-names>LJ</given-names></name>, <name><surname>Matrisian</surname><given-names>LM</given-names></name>
<article-title>Tumor progression: Defining the soil round the tumor seed</article-title>. <source>Curr Biol</source>. <year>2001</year>;<volume>11</volume>: <fpage>R25</fpage>&#x02013;<lpage>R27</lpage>
<object-id pub-id-type="pmid">11166192</object-id><pub-id pub-id-type="pmid">11166192</pub-id></mixed-citation></ref><ref id="pone.0119539.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Coussens</surname><given-names>LM</given-names></name>, <name><surname>Tinkle</surname><given-names>CL</given-names></name>, <name><surname>Hanahan</surname><given-names>D</given-names></name>, <name><surname>Werb</surname><given-names>Z</given-names></name>
<article-title>MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis</article-title>. <source>Cell</source>. <year>2000</year>;<volume>103</volume>: <fpage>481</fpage>&#x02013;<lpage>490</lpage>
<object-id pub-id-type="pmid">11081634</object-id><pub-id pub-id-type="pmid">11081634</pub-id></mixed-citation></ref><ref id="pone.0119539.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Bergers</surname><given-names>G</given-names></name>, <name><surname>Brekken</surname><given-names>R</given-names></name>, <name><surname>McMahon</surname><given-names>G</given-names></name>, <name><surname>Vu</surname><given-names>TH</given-names></name>, <name><surname>Itoh</surname><given-names>T</given-names></name>, <name><surname>Tamaki</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis</article-title>. <source>Nat Cell Biol</source>. <year>2000</year>;<volume>2</volume>: <fpage>737</fpage>&#x02013;<lpage>744</lpage>
<object-id pub-id-type="pmid">11025665</object-id><pub-id pub-id-type="pmid">11025665</pub-id></mixed-citation></ref><ref id="pone.0119539.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Sehgal</surname><given-names>I</given-names></name>, <name><surname>Thompson</surname><given-names>TC</given-names></name>
<article-title>Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.</article-title><source>Mol Biol Cell</source>. <year>1999</year>;<volume>10</volume>: <fpage>407</fpage>&#x02013;<lpage>416</lpage>
<object-id pub-id-type="pmid">9950685</object-id><pub-id pub-id-type="pmid">9950685</pub-id></mixed-citation></ref><ref id="pone.0119539.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Akool el</surname><given-names>S</given-names></name>, <name><surname>Kleinert</surname><given-names>H</given-names></name>, <name><surname>Hamada</surname><given-names>FM</given-names></name>, <name><surname>Abdelwahab</surname><given-names>MH</given-names></name>, <name><surname>Forstermann</surname><given-names>U</given-names></name>, <name><surname>Pfeilschifter</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR</article-title>. <source>Mol Cell Biol</source>. <year>2003</year>;<volume>23</volume>: <fpage>4901</fpage>&#x02013;<lpage>4916</lpage>
<object-id pub-id-type="pmid">12832476</object-id><pub-id pub-id-type="pmid">12832476</pub-id></mixed-citation></ref><ref id="pone.0119539.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Huwiler</surname><given-names>A</given-names></name>, <name><surname>Akool el</surname><given-names>S</given-names></name>, <name><surname>Aschrafi</surname><given-names>A</given-names></name>, <name><surname>Hamada</surname><given-names>FM</given-names></name>, <name><surname>Pfeilschifter</surname><given-names>J</given-names></name>, <name><surname>Eberhardt</surname><given-names>W</given-names></name>
<article-title>ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR</article-title>. <source>J Biol Chem</source>. <year>2003</year>;<volume>278</volume>: <fpage>51758</fpage>&#x02013;<lpage>51769</lpage>
<object-id pub-id-type="pmid">14523003</object-id><pub-id pub-id-type="pmid">14523003</pub-id></mixed-citation></ref><ref id="pone.0119539.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Iyer</surname><given-names>V</given-names></name>, <name><surname>Pumiglia</surname><given-names>K</given-names></name>, <name><surname>DiPersio</surname><given-names>CM</given-names></name>
<article-title>&#x003b1;3&#x003b2;1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression</article-title>. <source>J Cell Sci</source>. <year>2005</year>;<volume>118</volume>: <fpage>1185</fpage>&#x02013;<lpage>1195</lpage>
<object-id pub-id-type="pmid">15728252</object-id><pub-id pub-id-type="pmid">15728252</pub-id></mixed-citation></ref><ref id="pone.0119539.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Khabar</surname><given-names>KS</given-names></name>
<article-title>Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements</article-title>. <source>Cell Mol Life Sci</source>. <year>2010</year>;<volume>67</volume>: <fpage>2937</fpage>&#x02013;<lpage>2955</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00018-010-0383-x">10.1007/s00018-010-0383-x</ext-link></comment><object-id pub-id-type="pmid">20495997</object-id><pub-id pub-id-type="pmid">20495997</pub-id></mixed-citation></ref><ref id="pone.0119539.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>X</given-names></name>, <name><surname>Brewer</surname><given-names>G</given-names></name>
<article-title>The regulation of mRNA stability in mammalian cells: 2.0</article-title>. <source>Gene</source>. <year>2012</year>;<volume>500</volume>: <fpage>10</fpage>&#x02013;<lpage>21</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.gene.2012.03.021">10.1016/j.gene.2012.03.021</ext-link></comment><object-id pub-id-type="pmid">22452843</object-id><pub-id pub-id-type="pmid">22452843</pub-id></mixed-citation></ref><ref id="pone.0119539.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Lopez de Silanes</surname><given-names>I</given-names></name>, <name><surname>Zhan</surname><given-names>M</given-names></name>, <name><surname>Lal</surname><given-names>A</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <name><surname>Gorospe</surname><given-names>M</given-names></name>
<article-title>Identification of a target RNA motif for RNA-binding protein HuR</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2004</year>;<volume>101</volume>: <fpage>2987</fpage>&#x02013;<lpage>2992</lpage>
<object-id pub-id-type="pmid">14981256</object-id><pub-id pub-id-type="pmid">14981256</pub-id></mixed-citation></ref><ref id="pone.0119539.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Halees</surname><given-names>AS</given-names></name>, <name><surname>El-Badrawi</surname><given-names>R</given-names></name>, <name><surname>Khabar</surname><given-names>KS</given-names></name>
<article-title>ARED Organism: expansion of ARED reveals AU-rich element cluster variations between human and mouse</article-title>. <source>Nucleic Acids Res</source>. <year>2008</year>;<volume>36</volume>: <fpage>D137</fpage>&#x02013;<lpage>140</lpage>
<object-id pub-id-type="pmid">17984078</object-id><pub-id pub-id-type="pmid">17984078</pub-id></mixed-citation></ref><ref id="pone.0119539.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>JG</given-names></name>, <name><surname>Collinge</surname><given-names>M</given-names></name>, <name><surname>Ramgolam</surname><given-names>V</given-names></name>, <name><surname>Ayalon</surname><given-names>O</given-names></name>, <name><surname>Fan</surname><given-names>XC</given-names></name>, <name><surname>Pardi</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization in T cell activation</article-title>. <source>J Immunol</source>. <year>2006</year>;<volume>176</volume>: <fpage>2105</fpage>&#x02013;<lpage>2113</lpage>
<object-id pub-id-type="pmid">16455966</object-id><pub-id pub-id-type="pmid">16455966</pub-id></mixed-citation></ref><ref id="pone.0119539.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>B</given-names></name>, <name><surname>Manley</surname><given-names>JL</given-names></name>
<article-title>Alternative cleavage and polyadenylation: the long and short of it</article-title>. <source>Trends Biochem Sci</source>. <year>2013</year>;<volume>38</volume>: <fpage>312</fpage>&#x02013;<lpage>320</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.tibs.2013.03.005">10.1016/j.tibs.2013.03.005</ext-link></comment><object-id pub-id-type="pmid">23632313</object-id><pub-id pub-id-type="pmid">23632313</pub-id></mixed-citation></ref><ref id="pone.0119539.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>AR</given-names></name>, <name><surname>Bos</surname><given-names>A</given-names></name>, <name><surname>Diosdado</surname><given-names>B</given-names></name>, <name><surname>Rooijers</surname><given-names>K</given-names></name>, <name><surname>Elkon</surname><given-names>R</given-names></name>, <name><surname>Bolijn</surname><given-names>AS</given-names></name>, <etal>et al</etal>
<article-title>Alternative Cleavage and Polyadenylation during Colorectal Cancer Development</article-title>. <source>Clin Cancer Res</source>. <year>2012</year>;<volume>18</volume>: <fpage>5256</fpage>&#x02013;<lpage>5266</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/1078-0432.CCR-12-0543">10.1158/1078-0432.CCR-12-0543</ext-link></comment><object-id pub-id-type="pmid">22874640</object-id><pub-id pub-id-type="pmid">22874640</pub-id></mixed-citation></ref><ref id="pone.0119539.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>Z</given-names></name>, <name><surname>Ozsolak</surname><given-names>F</given-names></name>, <name><surname>Kim</surname><given-names>SW</given-names></name>, <name><surname>Arango-Argoty</surname><given-names>G</given-names></name>, <name><surname>Liu</surname><given-names>TT</given-names></name>, <etal>et al</etal>
<article-title>An in-depth map of polyadenylation sites in cancer</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>: <fpage>8460</fpage>&#x02013;<lpage>8471</lpage>
<object-id pub-id-type="pmid">22753024</object-id><pub-id pub-id-type="pmid">22753024</pub-id></mixed-citation></ref><ref id="pone.0119539.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Mayr</surname><given-names>C</given-names></name>, <name><surname>Bartel</surname><given-names>DP</given-names></name>
<article-title>Widespread Shortening of 3&#x02032;UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells</article-title>. <source>Cell</source>. <year>2009</year>;<volume>138</volume>: <fpage>673</fpage>&#x02013;<lpage>684</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.cell.2009.06.016">10.1016/j.cell.2009.06.016</ext-link></comment><object-id pub-id-type="pmid">19703394</object-id><pub-id pub-id-type="pmid">19703394</pub-id></mixed-citation></ref><ref id="pone.0119539.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Missan</surname><given-names>DS</given-names></name>, <name><surname>DiPersio</surname><given-names>CM</given-names></name>
<article-title>Integrin control of tumor invasion</article-title>. <source>Crit Rev Eukaryot Gene Expr</source>. <year>2012</year>;<volume>22</volume>: <fpage>309</fpage>&#x02013;<lpage>324</lpage>
<object-id pub-id-type="pmid">23272801</object-id><pub-id pub-id-type="pmid">23272801</pub-id></mixed-citation></ref><ref id="pone.0119539.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Shell</surname><given-names>SA</given-names></name>, <name><surname>Hesse</surname><given-names>C</given-names></name>, <name><surname>Morris</surname><given-names>SM</given-names><suffix>Jr</suffix></name>, <name><surname>Milcarek</surname><given-names>C</given-names></name>
<article-title>Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection</article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>: <fpage>39950</fpage>&#x02013;<lpage>39961</lpage>
<object-id pub-id-type="pmid">16207706</object-id><pub-id pub-id-type="pmid">16207706</pub-id></mixed-citation></ref><ref id="pone.0119539.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>K</given-names></name>, <name><surname>Szekeres</surname><given-names>C</given-names></name>, <name><surname>Milano</surname><given-names>V</given-names></name>, <name><surname>Svenson</surname><given-names>KB</given-names></name>, <name><surname>Nilsen-Hamilton</surname><given-names>M</given-names></name>, <name><surname>Kreidberg</surname><given-names>JA</given-names></name>, <etal>et al</etal>
<article-title>&#x003b1;3&#x003b2;1 integrin in epidermis promotes wound angiogenesis and keratinocyte-to-endothelial-cell crosstalk through the induction of MRP3</article-title>. <source>J Cell Sci</source>. <year>2009</year>;<volume>122</volume>: <fpage>1778</fpage>&#x02013;<lpage>1787</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/jcs.040956">10.1242/jcs.040956</ext-link></comment><object-id pub-id-type="pmid">19435806</object-id><pub-id pub-id-type="pmid">19435806</pub-id></mixed-citation></ref><ref id="pone.0119539.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Fan</surname><given-names>XC</given-names></name>, <name><surname>Steitz</surname><given-names>JA</given-names></name>
<article-title>Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs</article-title>. <source>EMBO J</source>. <year>1998</year>;<volume>17</volume>: <fpage>3448</fpage>&#x02013;<lpage>3460</lpage>
<object-id pub-id-type="pmid">9628880</object-id><pub-id pub-id-type="pmid">9628880</pub-id></mixed-citation></ref><ref id="pone.0119539.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Eberhardt</surname><given-names>W</given-names></name>, <name><surname>Schulze</surname><given-names>M</given-names></name>, <name><surname>Engels</surname><given-names>C</given-names></name>, <name><surname>Klasmeier</surname><given-names>E</given-names></name>, <name><surname>Pfeilschifter</surname><given-names>J</given-names></name>
<article-title>Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors</article-title>. <source>Mol Endocrinol</source>. <year>2002</year>;<volume>16</volume>: <fpage>1752</fpage>&#x02013;<lpage>1766</lpage>
<object-id pub-id-type="pmid">12145332</object-id><pub-id pub-id-type="pmid">12145332</pub-id></mixed-citation></ref><ref id="pone.0119539.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Woods</surname><given-names>D</given-names></name>, <name><surname>Cherwinski</surname><given-names>H</given-names></name>, <name><surname>Venetsanakos</surname><given-names>E</given-names></name>, <name><surname>Bhat</surname><given-names>A</given-names></name>, <name><surname>Gysin</surname><given-names>S</given-names></name>, <name><surname>Humbert</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway</article-title>. <source>Mol Cell Biol</source>. <year>2001</year>;<volume>21</volume>: <fpage>3192</fpage>&#x02013;<lpage>3205</lpage>
<object-id pub-id-type="pmid">11287623</object-id><pub-id pub-id-type="pmid">11287623</pub-id></mixed-citation></ref><ref id="pone.0119539.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>TC</given-names></name>, <name><surname>Zhou</surname><given-names>S</given-names></name>, <name><surname>da Costa</surname><given-names>LT</given-names></name>, <name><surname>Yu</surname><given-names>J</given-names></name>, <name><surname>Kinzler</surname><given-names>KW</given-names></name>, <name><surname>Vogelstein</surname><given-names>B</given-names></name>
<article-title>A simplified system for generating recombinant adenoviruses</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1998</year>;<volume>95</volume>: <fpage>2509</fpage>&#x02013;<lpage>2514</lpage>
<object-id pub-id-type="pmid">9482916</object-id><pub-id pub-id-type="pmid">9482916</pub-id></mixed-citation></ref><ref id="pone.0119539.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Meadows</surname><given-names>KN</given-names></name>, <name><surname>Bryant</surname><given-names>P</given-names></name>, <name><surname>Pumiglia</surname><given-names>K</given-names></name>
<article-title>Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation</article-title>. <source>J Biol Chem</source>. <year>2001</year>;<volume>276</volume>: <fpage>49289</fpage>&#x02013;<lpage>49298</lpage>
<object-id pub-id-type="pmid">11682481</object-id><pub-id pub-id-type="pmid">11682481</pub-id></mixed-citation></ref><ref id="pone.0119539.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>DiPersio</surname><given-names>CM</given-names></name>, <name><surname>Shah</surname><given-names>S</given-names></name>, <name><surname>Hynes</surname><given-names>RO</given-names></name>
<article-title>&#x003b1;3A&#x003b2;1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins</article-title>. <source>J Cell Sci</source>. <year>1995</year>;<volume>108</volume>: <fpage>2321</fpage>&#x02013;<lpage>2336</lpage>
<object-id pub-id-type="pmid">7673352</object-id><pub-id pub-id-type="pmid">7673352</pub-id></mixed-citation></ref><ref id="pone.0119539.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Tanaka</surname><given-names>H</given-names></name>, <name><surname>Hojo</surname><given-names>K</given-names></name>, <name><surname>Yoshida</surname><given-names>H</given-names></name>, <name><surname>Yoshioka</surname><given-names>T</given-names></name>, <name><surname>Sugita</surname><given-names>K</given-names></name>
<article-title>Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA</article-title>. <source>Biochem Biophys Res Commun</source>. <year>1993</year>;<volume>190</volume>: <fpage>732</fpage>&#x02013;<lpage>740</lpage>
<object-id pub-id-type="pmid">8382489</object-id><pub-id pub-id-type="pmid">8382489</pub-id></mixed-citation></ref><ref id="pone.0119539.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Okada</surname><given-names>A</given-names></name>, <name><surname>Santavicca</surname><given-names>M</given-names></name>, <name><surname>Basset</surname><given-names>P</given-names></name>
<article-title>The cDNA cloning and expression of the gene encoding rat gelatinase B</article-title>. <source>Gene</source>. <year>1995</year>;<volume>164</volume>: <fpage>317</fpage>&#x02013;<lpage>321</lpage>
<object-id pub-id-type="pmid">7590350</object-id><pub-id pub-id-type="pmid">7590350</pub-id></mixed-citation></ref><ref id="pone.0119539.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Xia</surname><given-names>Y</given-names></name>, <name><surname>Garcia</surname><given-names>G</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Wilson</surname><given-names>CB</given-names></name>, <name><surname>Feng</surname><given-names>L</given-names></name>
<article-title>Cloning of rat 92-kDa type IV collagenase and expression of an active recombinant catalytic domain</article-title>. <source>FEBS Lett</source>. <year>1996</year>;<volume>382</volume>: <fpage>285</fpage>&#x02013;<lpage>288</lpage>
<object-id pub-id-type="pmid">8605986</object-id><pub-id pub-id-type="pmid">8605986</pub-id></mixed-citation></ref><ref id="pone.0119539.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Masure</surname><given-names>S</given-names></name>, <name><surname>Nys</surname><given-names>G</given-names></name>, <name><surname>Fiten</surname><given-names>P</given-names></name>, <name><surname>Van Damme</surname><given-names>J</given-names></name>, <name><surname>Opdenakker</surname><given-names>G</given-names></name>
<article-title>Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organisation</article-title>. <source>Eur J Biochem</source>. <year>1993</year>;<volume>218</volume>: <fpage>129</fpage>&#x02013;<lpage>141</lpage>
<object-id pub-id-type="pmid">8243459</object-id><pub-id pub-id-type="pmid">8243459</pub-id></mixed-citation></ref><ref id="pone.0119539.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Missan</surname><given-names>DS</given-names></name>, <name><surname>Chittur</surname><given-names>SV</given-names></name>, <name><surname>DiPersio</surname><given-names>CM</given-names></name>
<article-title>Regulation of Fibulin-2 Gene Expression by Integrin &#x003b1;3&#x003b2;1 Contributes to the Invasive Phenotype of Transformed Keratinocytes</article-title>. <source>J Invest Dermatol</source>. <year>2014</year>;<volume>134</volume>: <fpage>2418</fpage>&#x02013;<lpage>2427</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/jid.2014.166">10.1038/jid.2014.166</ext-link></comment><object-id pub-id-type="pmid">24694902</object-id><pub-id pub-id-type="pmid">24694902</pub-id></mixed-citation></ref><ref id="pone.0119539.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>McCawley</surname><given-names>LJ</given-names></name>, <name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Wattenberg</surname><given-names>EV</given-names></name>, <name><surname>Hudson</surname><given-names>LG</given-names></name>
<article-title>Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>: <fpage>4347</fpage>&#x02013;<lpage>4353</lpage>
<object-id pub-id-type="pmid">9933637</object-id><pub-id pub-id-type="pmid">9933637</pub-id></mixed-citation></ref><ref id="pone.0119539.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Thant</surname><given-names>AA</given-names></name>, <name><surname>Nawa</surname><given-names>A</given-names></name>, <name><surname>Kikkawa</surname><given-names>F</given-names></name>, <name><surname>Ichigotani</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Sein</surname><given-names>TT</given-names></name>, <etal>et al</etal>
<article-title>Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells</article-title>. <source>Clin Exp Metastasis</source>. <year>2000</year>;<volume>18</volume>: <fpage>423</fpage>&#x02013;<lpage>428</lpage>
<object-id pub-id-type="pmid">11467775</object-id><pub-id pub-id-type="pmid">11467775</pub-id></mixed-citation></ref><ref id="pone.0119539.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Manohar</surname><given-names>A</given-names></name>, <name><surname>Shome</surname><given-names>SG</given-names></name>, <name><surname>Lamar</surname><given-names>J</given-names></name>, <name><surname>Stirling</surname><given-names>L</given-names></name>, <name><surname>Iyer</surname><given-names>V</given-names></name>, <name><surname>Pumiglia</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>&#x003b1;3&#x003b2;1 integrin promotes keratinocyte cell survival through activation of a MEK/ERK signaling pathway</article-title>. <source>J Cell Sci</source>. <year>2004</year>;<volume>117</volume>: <fpage>4043</fpage>&#x02013;<lpage>4054</lpage>
<object-id pub-id-type="pmid">15280429</object-id><pub-id pub-id-type="pmid">15280429</pub-id></mixed-citation></ref><ref id="pone.0119539.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Elkon</surname><given-names>R</given-names></name>, <name><surname>Ugalde</surname><given-names>AP</given-names></name>, <name><surname>Agami</surname><given-names>R</given-names></name>
<article-title>Alternative cleavage and polyadenylation: extent, regulation and function</article-title>. <source>Nat Rev Genet</source>. <year>2013</year>;<volume>14</volume>: <fpage>496</fpage>&#x02013;<lpage>506</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrg3482">10.1038/nrg3482</ext-link></comment><object-id pub-id-type="pmid">23774734</object-id><pub-id pub-id-type="pmid">23774734</pub-id></mixed-citation></ref><ref id="pone.0119539.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Brennan</surname><given-names>CM</given-names></name>, <name><surname>Steitz</surname><given-names>JA</given-names></name>
<article-title>HuR and mRNA stability</article-title>. <source>Cell Mol Life Sci</source>. <year>2001</year>;<volume>58</volume>: <fpage>266</fpage>&#x02013;<lpage>277</lpage>
<object-id pub-id-type="pmid">11289308</object-id><pub-id pub-id-type="pmid">11289308</pub-id></mixed-citation></ref><ref id="pone.0119539.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Keyomarsi</surname><given-names>K</given-names></name>, <name><surname>Pardee</surname><given-names>AB</given-names></name>
<article-title>Redundant cyclin overexpression and gene amplification in breast cancer cells</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1993</year>;<volume>90</volume>: <fpage>1112</fpage>&#x02013;<lpage>1116</lpage>
<object-id pub-id-type="pmid">8430082</object-id><pub-id pub-id-type="pmid">8430082</pub-id></mixed-citation></ref><ref id="pone.0119539.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Lebwohl</surname><given-names>DE</given-names></name>, <name><surname>Muise-Helmericks</surname><given-names>R</given-names></name>, <name><surname>Sepp-Lorenzino</surname><given-names>L</given-names></name>, <name><surname>Serve</surname><given-names>S</given-names></name>, <name><surname>Timaul</surname><given-names>M</given-names></name>, <name><surname>Bol</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line</article-title>. <source>Oncogene</source>. <year>1994</year>;<volume>9</volume>: <fpage>1925</fpage>&#x02013;<lpage>1929</lpage>
<object-id pub-id-type="pmid">8208539</object-id><pub-id pub-id-type="pmid">8208539</pub-id></mixed-citation></ref><ref id="pone.0119539.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Dixon</surname><given-names>DA</given-names></name>, <name><surname>Tolley</surname><given-names>ND</given-names></name>, <name><surname>King</surname><given-names>PH</given-names></name>, <name><surname>Nabors</surname><given-names>LB</given-names></name>, <name><surname>McIntyre</surname><given-names>TM</given-names></name>, <name><surname>Zimmerman</surname><given-names>GA</given-names></name>, <etal>et al</etal>
<article-title>Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells</article-title>. <source>J Clin Invest</source>. <year>2001</year>;<volume>108</volume>: <fpage>1657</fpage>&#x02013;<lpage>1665</lpage>
<object-id pub-id-type="pmid">11733561</object-id><pub-id pub-id-type="pmid">11733561</pub-id></mixed-citation></ref><ref id="pone.0119539.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Subbaram</surname><given-names>S</given-names></name>, <name><surname>Lyons</surname><given-names>SP</given-names></name>, <name><surname>Svenson</surname><given-names>KB</given-names></name>, <name><surname>Hammond</surname><given-names>SL</given-names></name>, <name><surname>McCabe</surname><given-names>LG</given-names></name>, <name><surname>Chittur</surname><given-names>SV</given-names></name>, <etal>et al</etal>
<article-title>Integrin &#x003b1;3&#x003b2;1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells</article-title>. <source>J Cell Sci</source>. <year>2014</year>;<volume>127</volume>: <fpage>1179</fpage>&#x02013;<lpage>1189</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1242/jcs.131227">10.1242/jcs.131227</ext-link></comment><object-id pub-id-type="pmid">24434582</object-id><pub-id pub-id-type="pmid">24434582</pub-id></mixed-citation></ref><ref id="pone.0119539.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Ernst</surname><given-names>J</given-names></name>, <name><surname>Ghanem</surname><given-names>L</given-names></name>, <name><surname>Bar-Joseph</surname><given-names>Z</given-names></name>, <name><surname>McNamara</surname><given-names>M</given-names></name>, <name><surname>Brown</surname><given-names>J</given-names></name>, <name><surname>Steinman</surname><given-names>RA</given-names></name>
<article-title>IL-3 and oncogenic Abl regulate the myeloblast transcriptome by altering mRNA stability</article-title>. <source>PLoS One</source>. <year>2009</year>;<volume>4</volume>: <fpage>e7469</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0007469">10.1371/journal.pone.0007469</ext-link></comment><object-id pub-id-type="pmid">19829692</object-id><pub-id pub-id-type="pmid">19829692</pub-id></mixed-citation></ref><ref id="pone.0119539.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Headley</surname><given-names>VV</given-names></name>, <name><surname>Tanveer</surname><given-names>R</given-names></name>, <name><surname>Greene</surname><given-names>SM</given-names></name>, <name><surname>Zweifach</surname><given-names>A</given-names></name>, <name><surname>Port</surname><given-names>JD</given-names></name>
<article-title>Reciprocal regulation of beta-adrenergic receptor mRNA stability by mitogen activated protein kinase activation and inhibition</article-title>. <source>Mol Cell Biochem</source>. <year>2004</year>;<volume>258</volume>: <fpage>109</fpage>&#x02013;<lpage>119</lpage>
<object-id pub-id-type="pmid">15030175</object-id><pub-id pub-id-type="pmid">15030175</pub-id></mixed-citation></ref><ref id="pone.0119539.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Yu</surname><given-names>T</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Helman</surname><given-names>JI</given-names></name>, <name><surname>Wen</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>C</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>
<article-title>CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway</article-title>. <source>Mol Cancer Res</source>. <year>2011</year>;<volume>9</volume>: <fpage>161</fpage>&#x02013;<lpage>172</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/1541-7786.MCR-10-0386">10.1158/1541-7786.MCR-10-0386</ext-link></comment><object-id pub-id-type="pmid">21205837</object-id><pub-id pub-id-type="pmid">21205837</pub-id></mixed-citation></ref><ref id="pone.0119539.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>CH</given-names></name>, <name><surname>Tsai</surname><given-names>CC</given-names></name>
<article-title>CCL2 increases MMP-9 expression and cell motility in human chondrosarcoma cells via the Ras/Raf/MEK/ERK/NF-kappaB signaling pathway</article-title>. <source>Biochem Pharmacol</source>. <year>2012</year>;<volume>83</volume>: <fpage>335</fpage>&#x02013;<lpage>344</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bcp.2011.11.013">10.1016/j.bcp.2011.11.013</ext-link></comment><object-id pub-id-type="pmid">22138288</object-id><pub-id pub-id-type="pmid">22138288</pub-id></mixed-citation></ref><ref id="pone.0119539.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Choi</surname><given-names>JH</given-names></name>, <name><surname>Lim</surname><given-names>HI</given-names></name>, <name><surname>Lee</surname><given-names>SK</given-names></name>, <name><surname>Kim</surname><given-names>WW</given-names></name>, <name><surname>Kim</surname><given-names>JS</given-names></name>, <etal>et al</etal>
<article-title>Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells</article-title>. <source>Phytomedicine</source>. <year>2009</year>;<volume>16</volume>: <fpage>573</fpage>&#x02013;<lpage>580</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.phymed.2008.11.006">10.1016/j.phymed.2008.11.006</ext-link></comment><object-id pub-id-type="pmid">19181503</object-id><pub-id pub-id-type="pmid">19181503</pub-id></mixed-citation></ref><ref id="pone.0119539.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>P</given-names></name>, <name><surname>Wilson</surname><given-names>MJ</given-names></name>
<article-title>miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-kappaB factor in human fibrosarcoma cells</article-title>. <source>J Cell Physiol</source>. <year>2012</year>;<volume>227</volume>: <fpage>867</fpage>&#x02013;<lpage>876</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/jcp.22993">10.1002/jcp.22993</ext-link></comment><object-id pub-id-type="pmid">21898400</object-id><pub-id pub-id-type="pmid">21898400</pub-id></mixed-citation></ref><ref id="pone.0119539.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>L-J</given-names></name>, <name><surname>Lin</surname><given-names>P</given-names></name>, <name><surname>Lin</surname><given-names>F</given-names></name>, <name><surname>Liu</surname><given-names>X</given-names></name>, <name><surname>Qin</surname><given-names>W</given-names></name>, <name><surname>Zou</surname><given-names>HF</given-names></name>, <etal>et al</etal>
<article-title>ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion</article-title>. <source>Int. J Oncol.</source><year>2012</year>;<volume>40</volume>: <fpage>1714</fpage>&#x02013;<lpage>1724</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3892/ijo.2011.1320">10.3892/ijo.2011.1320</ext-link></comment><object-id pub-id-type="pmid">22200661</object-id><pub-id pub-id-type="pmid">22200661</pub-id></mixed-citation></ref><ref id="pone.0119539.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Poudel</surname><given-names>B</given-names></name>, <name><surname>Kim</surname><given-names>DK</given-names></name>, <name><surname>Ki</surname><given-names>HH</given-names></name>, <name><surname>Kwon</surname><given-names>YB</given-names></name>, <name><surname>Lee</surname><given-names>YM</given-names></name>, <name><surname>Kim</surname><given-names>DK</given-names></name>
<article-title>Downregulation of ERK signaling impairs U2OS osteosarcoma cell migration in collagen matrix by suppressing MMP9 production</article-title>. <source>Oncol Lett</source>. <year>2014</year>;<volume>7</volume>: <fpage>215</fpage>&#x02013;<lpage>218</lpage>
<object-id pub-id-type="pmid">24348851</object-id><pub-id pub-id-type="pmid">24348851</pub-id></mixed-citation></ref><ref id="pone.0119539.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Das</surname><given-names>G</given-names></name>, <name><surname>Shiras</surname><given-names>A</given-names></name>, <name><surname>Shanmuganandam</surname><given-names>K</given-names></name>, <name><surname>Shastry</surname><given-names>P</given-names></name>
<article-title>Rictor regulates MMP&#x02010;9 activity and invasion through Raf&#x02010;1&#x02010;MEK&#x02010;ERK signaling pathway in glioma cells</article-title>. <source>Mol Carcinog</source>. <year>2011</year>;<volume>50</volume>: <fpage>412</fpage>&#x02013;<lpage>423</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/mc.20723">10.1002/mc.20723</ext-link></comment><object-id pub-id-type="pmid">21557327</object-id><pub-id pub-id-type="pmid">21557327</pub-id></mixed-citation></ref><ref id="pone.0119539.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Hoque</surname><given-names>M</given-names></name>, <name><surname>Ji</surname><given-names>Z</given-names></name>, <name><surname>Zheng</surname><given-names>D</given-names></name>, <name><surname>Luo</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>You</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Analysis of alternative cleavage and polyadenylation by 3' region extraction and deep sequencing</article-title>. <source>Nat Methods</source><year>2013</year>;<volume>10</volume>: <fpage>133</fpage>&#x02013;<lpage>139</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth.2288">10.1038/nmeth.2288</ext-link></comment><object-id pub-id-type="pmid">23241633</object-id><pub-id pub-id-type="pmid">23241633</pub-id></mixed-citation></ref><ref id="pone.0119539.ref059"><label>59</label><mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>Z</given-names></name>, <name><surname>Lee</surname><given-names>JY</given-names></name>, <name><surname>Pan</surname><given-names>Z</given-names></name>, <name><surname>Jiang</surname><given-names>B</given-names></name>, <name><surname>Tian</surname><given-names>B</given-names></name>
<article-title>Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2009</year>;<volume>106</volume>: <fpage>7028</fpage>&#x02013;<lpage>7033</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0900028106">10.1073/pnas.0900028106</ext-link></comment><object-id pub-id-type="pmid">19372383</object-id><pub-id pub-id-type="pmid">19372383</pub-id></mixed-citation></ref><ref id="pone.0119539.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Sandberg</surname><given-names>R</given-names></name>, <name><surname>Neilson</surname><given-names>JR</given-names></name>, <name><surname>Sarma</surname><given-names>A</given-names></name>, <name><surname>Sharp</surname><given-names>PA</given-names></name>, <name><surname>Burge</surname><given-names>CB</given-names></name>
<article-title>Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites</article-title>. <source>Science</source>. <year>2008</year>;<volume>320</volume>: <fpage>1643</fpage>&#x02013;<lpage>1647</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1155390">10.1126/science.1155390</ext-link></comment><object-id pub-id-type="pmid">18566288</object-id><pub-id pub-id-type="pmid">18566288</pub-id></mixed-citation></ref><ref id="pone.0119539.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Naipauer</surname><given-names>J</given-names></name>, <name><surname>Gattelli</surname><given-names>A</given-names></name>, <name><surname>Degese</surname><given-names>MS</given-names></name>, <name><surname>Slomiansky</surname><given-names>V</given-names></name>, <name><surname>Wertheimer</surname><given-names>E</given-names></name>, <name><surname>LaMarre</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>The use of alternative polyadenylation sites renders integrin beta1 (Itgb1) mRNA isoforms with differential stability during mammary gland development</article-title>. <source>Biochem J</source>. <year>2013</year>;<volume>454</volume>: <fpage>345</fpage>&#x02013;<lpage>357</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1042/BJ20130062">10.1042/BJ20130062</ext-link></comment><object-id pub-id-type="pmid">23789592</object-id><pub-id pub-id-type="pmid">23789592</pub-id></mixed-citation></ref><ref id="pone.0119539.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Dai</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>G</given-names></name>, <name><surname>Makeyev</surname><given-names>EV</given-names></name>
<article-title>RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>40</volume>: <fpage>787</fpage>&#x02013;<lpage>800</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkr783">10.1093/nar/gkr783</ext-link></comment><object-id pub-id-type="pmid">21948791</object-id><pub-id pub-id-type="pmid">21948791</pub-id></mixed-citation></ref><ref id="pone.0119539.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>D</given-names></name>, <name><surname>Fritz</surname><given-names>DT</given-names></name>, <name><surname>Rogers</surname><given-names>MB</given-names></name>, <name><surname>Shatkin</surname><given-names>AJ</given-names></name>
<article-title>Species-specific cis-regulatory elements in the 3'-untranslated region direct alternative polyadenylation of bone morphogenetic protein 2 mRNA</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>: <fpage>28010</fpage>&#x02013;<lpage>28019</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M804895200">10.1074/jbc.M804895200</ext-link></comment><object-id pub-id-type="pmid">18703506</object-id><pub-id pub-id-type="pmid">18703506</pub-id></mixed-citation></ref><ref id="pone.0119539.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Touriol</surname><given-names>C</given-names></name>, <name><surname>Morillon</surname><given-names>A</given-names></name>, <name><surname>Gensac</surname><given-names>MC</given-names></name>, <name><surname>Prats</surname><given-names>H</given-names></name>, <name><surname>Prats</surname><given-names>AC</given-names></name>
<article-title>Expression of human fibroblast growth factor 2 mRNA is post-transcriptionally controlled by a unique destabilizing element present in the 3'-untranslated region between alternative polyadenylation sites</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>: <fpage>21402</fpage>&#x02013;<lpage>21408</lpage>
<object-id pub-id-type="pmid">10409702</object-id><pub-id pub-id-type="pmid">10409702</pub-id></mixed-citation></ref><ref id="pone.0119539.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Hall-Pogar</surname><given-names>T</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Tian</surname><given-names>B</given-names></name>, <name><surname>Lutz</surname><given-names>CS</given-names></name>
<article-title>Alternative polyadenylation of cyclooxygenase-2</article-title>. <source>Nucleic Acids Res</source>. <year>2005</year>;<volume>33</volume>: <fpage>2565</fpage>&#x02013;<lpage>2579</lpage>
<object-id pub-id-type="pmid">15872218</object-id><pub-id pub-id-type="pmid">15872218</pub-id></mixed-citation></ref><ref id="pone.0119539.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Ji</surname><given-names>Z</given-names></name>, <name><surname>Luo</surname><given-names>W</given-names></name>, <name><surname>Li</surname><given-names>W</given-names></name>, <name><surname>Hoque</surname><given-names>M</given-names></name>, <name><surname>Pan</surname><given-names>Z</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Transcriptional activity regulates alternative cleavage and polyadenylation</article-title>. <source>Mol Syst Biol</source>. <year>2011</year>;<volume>7</volume>: <fpage>534</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/msb.2011.69">10.1038/msb.2011.69</ext-link></comment><object-id pub-id-type="pmid">21952137</object-id><pub-id pub-id-type="pmid">21952137</pub-id></mixed-citation></ref><ref id="pone.0119539.ref067"><label>67</label><mixed-citation publication-type="journal"><name><surname>Sachs</surname><given-names>N</given-names></name>, <name><surname>Secades</surname><given-names>P</given-names></name>, <name><surname>van Hulst</surname><given-names>L</given-names></name>, <name><surname>Kreft</surname><given-names>M</given-names></name>, <name><surname>Song</surname><given-names>JY</given-names></name>, <name><surname>Sonnenberg</surname><given-names>A</given-names></name>
<article-title>Loss of integrin alpha3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2012</year>;<volume>109</volume>: <fpage>21468</fpage>&#x02013;<lpage>21473</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1204614110">10.1073/pnas.1204614110</ext-link></comment><object-id pub-id-type="pmid">23236172</object-id><pub-id pub-id-type="pmid">23236172</pub-id></mixed-citation></ref><ref id="pone.0119539.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>Yauch</surname><given-names>RL</given-names></name>, <name><surname>Berditchevski</surname><given-names>F</given-names></name>, <name><surname>Harler</surname><given-names>MB</given-names></name>, <name><surname>Reichner</surname><given-names>J</given-names></name>, <name><surname>Hemler</surname><given-names>ME</given-names></name>
<article-title>Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration</article-title>. <source>Mol Biol Cell</source>. <year>1998</year>;<volume>9</volume>: <fpage>2751</fpage>&#x02013;<lpage>2765</lpage>
<object-id pub-id-type="pmid">9763442</object-id><pub-id pub-id-type="pmid">9763442</pub-id></mixed-citation></ref><ref id="pone.0119539.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Hemler</surname><given-names>ME</given-names></name>
<article-title>Tetraspanin functions and associated microdomains</article-title>. <source>Nat Rev Mol Cell Biol</source>. <year>2005</year>;<volume>6</volume>: <fpage>801</fpage>&#x02013;<lpage>811</lpage>
<object-id pub-id-type="pmid">16314869</object-id><pub-id pub-id-type="pmid">16314869</pub-id></mixed-citation></ref><ref id="pone.0119539.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Zevian</surname><given-names>S</given-names></name>, <name><surname>Winterwood</surname><given-names>NE</given-names></name>, <name><surname>Stipp</surname><given-names>CS</given-names></name>
<article-title>Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by alpha3beta1 versus alpha6beta4 integrin</article-title>. <source>J Biol Chem</source>. <year>2011</year>;<volume>286</volume>: <fpage>7496</fpage>&#x02013;<lpage>7506</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M110.173583">10.1074/jbc.M110.173583</ext-link></comment><object-id pub-id-type="pmid">21193415</object-id><pub-id pub-id-type="pmid">21193415</pub-id></mixed-citation></ref><ref id="pone.0119539.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Novitskaya</surname><given-names>V</given-names></name>, <name><surname>Romanska</surname><given-names>H</given-names></name>, <name><surname>Dawoud</surname><given-names>M</given-names></name>, <name><surname>Jones</surname><given-names>JL</given-names></name>, <name><surname>Berditchevski</surname><given-names>F</given-names></name>
<article-title>Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ</article-title>. <source>Cancer Res</source>. <year>2010</year>;<volume>70</volume>: <fpage>4698</fpage>&#x02013;<lpage>4708</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1158/0008-5472.CAN-09-4330">10.1158/0008-5472.CAN-09-4330</ext-link></comment><object-id pub-id-type="pmid">20501858</object-id><pub-id pub-id-type="pmid">20501858</pub-id></mixed-citation></ref><ref id="pone.0119539.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Zijlstra</surname><given-names>A</given-names></name>, <name><surname>Lewis</surname><given-names>J</given-names></name>, <name><surname>Degryse</surname><given-names>B</given-names></name>, <name><surname>Stuhlmann</surname><given-names>H</given-names></name>, <name><surname>Quigley</surname><given-names>JP</given-names></name>
<article-title>The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151</article-title>. <source>Cancer Cell</source>. <year>2008</year>;<volume>13</volume>: <fpage>221</fpage>&#x02013;<lpage>234</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ccr.2008.01.031">10.1016/j.ccr.2008.01.031</ext-link></comment><object-id pub-id-type="pmid">18328426</object-id><pub-id pub-id-type="pmid">18328426</pub-id></mixed-citation></ref><ref id="pone.0119539.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Sugiura</surname><given-names>T</given-names></name>, <name><surname>Berditchevski</surname><given-names>F</given-names></name>
<article-title>Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2)</article-title>. <source>J Cell Biol</source>. <year>1999</year>;<volume>146</volume>: <fpage>1375</fpage>&#x02013;<lpage>1389</lpage>
<object-id pub-id-type="pmid">10491398</object-id><pub-id pub-id-type="pmid">10491398</pub-id></mixed-citation></ref><ref id="pone.0119539.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Ya&#x000f1;ez-M&#x000f3;</surname><given-names>M</given-names></name>, <name><surname>Barreiro</surname><given-names>O</given-names></name>, <name><surname>Gonzalo</surname><given-names>P</given-names></name>, <name><surname>Batista</surname><given-names>A</given-names></name>, <name><surname>Meg&#x000ed;as</surname><given-names>D</given-names></name>, <name><surname>Gen&#x000ed;s</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>MT1-MMP collagenolytic activity is regulated through association with tetraspanin CD151 in primary endothelial cells</article-title>. <source>Blood</source>. <year>2008</year>;<volume>112</volume>: <fpage>3217</fpage>&#x02013;<lpage>3226</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1182/blood-2008-02-139394">10.1182/blood-2008-02-139394</ext-link></comment><object-id pub-id-type="pmid">18663148</object-id><pub-id pub-id-type="pmid">18663148</pub-id></mixed-citation></ref><ref id="pone.0119539.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Shi</surname><given-names>GM</given-names></name>, <name><surname>Ke</surname><given-names>AW</given-names></name>, <name><surname>Zhou</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>XY</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Ding</surname><given-names>ZB</given-names></name>, <etal>et al</etal>
<article-title>CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma</article-title>. <source>Hepatology</source>. <year>2010</year>;<volume>52</volume>: <fpage>183</fpage>&#x02013;<lpage>196</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/hep.23661">10.1002/hep.23661</ext-link></comment><object-id pub-id-type="pmid">20578262</object-id><pub-id pub-id-type="pmid">20578262</pub-id></mixed-citation></ref><ref id="pone.0119539.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Hasegawa</surname><given-names>M</given-names></name>, <name><surname>Furuya</surname><given-names>M</given-names></name>, <name><surname>Kasuya</surname><given-names>Y</given-names></name>, <name><surname>Nishiyama</surname><given-names>M</given-names></name>, <name><surname>Sugiura</surname><given-names>T</given-names></name>
<article-title>CD151 dynamics in carcinoma-stroma interaction: integrin expression, adhesion strength and proteolytic activity</article-title>. <source>Lab Invest</source>. <year>2007</year>;<volume>87</volume>: <fpage>882</fpage>&#x02013;<lpage>92</lpage>
<object-id pub-id-type="pmid">17632541</object-id><pub-id pub-id-type="pmid">17632541</pub-id></mixed-citation></ref><ref id="pone.0119539.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Hu</surname><given-names>J</given-names></name>, <name><surname>Recce</surname><given-names>M</given-names></name>, <name><surname>Tian</surname><given-names>B</given-names></name>
<article-title>PolyA_DB: a database for mammalian mRNA polyadenylation</article-title>. <source>Nucleic Acids Res</source>. <year>2005</year>;<volume>33</volume>: <fpage>D116</fpage>&#x02013;<lpage>120</lpage>
<object-id pub-id-type="pmid">15608159</object-id><pub-id pub-id-type="pmid">15608159</pub-id></mixed-citation></ref></ref-list></back></article>